<html lang="en" class="pb-page js" data-request-id="94d6aed105070292-SJC"><head data-pb-dropzone="head"><style type="text/css" nonce="94d6aed105070292-SJC">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/qWS9iTyVK-sWrHfQUad0JO8f3A59vC_i7557QwahmM4zVyfIx4jCdyVSDjYsXEJcCVIJqbOacecLYIL-9KbPGA=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d6aed105070292-SJC">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.7299974496856104"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="articleType" content="Original Article">
<meta name="Specialties" content="Infectious Disease">
<meta name="topics" content="Vaccines|Coronavirus">
<meta name="articleCategory" content="Research"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2114114","title":"Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar","category":"Research","type":"Original Article","topics":"Vaccines|Coronavirus","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2021-12-09T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"Specialties\" content\u003d\"Infectious Disease\"/\u003e\n\u003cmeta name\u003d\"topics\" content\u003d\"Vaccines|Coronavirus\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2114114","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":[]};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d6aed105070292-SJC">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar"><meta name="dc.Creator" content="Hiam Chemaitelly"><meta name="dc.Creator" content="Patrick Tang"><meta name="dc.Creator" content="Mohammad R. Hasan"><meta name="dc.Creator" content="Sawsan AlMukdad"><meta name="dc.Creator" content="Hadi M. Yassine"><meta name="dc.Creator" content="Fatiha M. Benslimane"><meta name="dc.Creator" content="Hebah A. Al Khatib"><meta name="dc.Creator" content="Peter Coyle"><meta name="dc.Creator" content="Houssein H. Ayoub"><meta name="dc.Creator" content="Zaina Al Kanaani"><meta name="dc.Creator" content="Einas Al Kuwari"><meta name="dc.Creator" content="Andrew Jeremijenko"><meta name="dc.Creator" content="Anvar H. Kaleeckal"><meta name="dc.Creator" content="Ali N. Latif"><meta name="dc.Creator" content="Riyazuddin M. Shaik"><meta name="dc.Creator" content="Hanan F. Abdul Rahim"><meta name="dc.Creator" content="Gheyath K. Nasrallah"><meta name="dc.Creator" content="Mohamed G. Al Kuwari"><meta name="dc.Creator" content="Hamad E. Al Romaihi"><meta name="dc.Creator" content="Adeel A. Butt"><meta name="dc.Creator" content="Mohamed H. Al-Thani"><meta name="dc.Creator" content="Abdullatif Al Khal"><meta name="dc.Creator" content="Roberto Bertollini"><meta name="dc.Creator" content="Laith J. Abu-Raddad"><meta name="dc.Description" content="Waning of vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The persistence of BNT162b2 (Pfizer–..."><meta name="Description" content="Waning of vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The persistence of BNT162b2 (Pfizer–..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2021-12-09"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa2114114"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202112093852410"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="YXQYoa2114114"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright © 2021 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa2114114">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa2114114">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa2114114">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM">
        <meta property="og:title" content="Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2114114">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/21755fa7-b76f-4b1d-a183-00d2ea09ea80/nejmoa2114114_f1.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/21755fa7-b76f-4b1d-a183-00d2ea09ea80/nejmoa2114114_f1.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="Waning of vaccine protection against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The
persistence of BNT162b2 (Pfizer–...">
        <meta name="twitter:description" content="Waning of vaccine protection against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The
persistence of BNT162b2 (Pfizer–...">
    


    
    
        <meta property="og:image:width" content="2315">
    


    
    
        <meta property="og:image:height" content="3438">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2114114">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2114114">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;issue:issue:doi\:10.1056/nejm_2021.385.issue-24;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:MMS NextGen Website Group;pageGroup:string:Publication Pages;article:article:doi\:10.1056/NEJMoa2114114;subPage:string:Full Text;website:website:mms-site;journal:journal:nejms">
        <script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><link rel="preconnect" href="https://use.typekit.net"><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2114114" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2114114" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2114114" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2114114" class="inputDoi"><input type="hidden" value="H. Chemaitelly and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2021;385:e83" class="inputCitation"><input type="hidden" value="10-06-2021" class="inputEPubDate"><input type="hidden" value="December 2021" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d6aed105070292-SJC"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Hiam</span> <span property="familyName">Chemaitelly</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Patrick</span> <span property="familyName">Tang</span>, <span property="honorificSuffix">M.D., Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-1583-5484" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-1583-5484</a></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mohammad R.</span> <span property="familyName">Hasan</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Sawsan</span> <span property="familyName">AlMukdad</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Hadi M.</span> <span property="familyName">Yassine</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Fatiha M.</span> <span property="familyName">Benslimane</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Hebah A.</span> <span property="familyName">Al Khatib</span>, <span property="honorificSuffix">Ph.D.</span></span><span data-displayed-on="all">, <span data-action="reveal" tabindex="0" role="listitem">+16</span> </span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Peter</span> <span property="familyName">Coyle</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Houssein H.</span> <span property="familyName">Ayoub</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-2512-6657" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-2512-6657</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Zaina</span> <span property="familyName">Al Kanaani</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Einas</span> <span property="familyName">Al Kuwari</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Andrew</span> <span property="familyName">Jeremijenko</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Anvar H.</span> <span property="familyName">Kaleeckal</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Ali N.</span> <span property="familyName">Latif</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Riyazuddin M.</span> <span property="familyName">Shaik</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Hanan F.</span> <span property="familyName">Abdul Rahim</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gheyath K.</span> <span property="familyName">Nasrallah</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mohamed G.</span> <span property="familyName">Al Kuwari</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Hamad E.</span> <span property="familyName">Al Romaihi</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Adeel A.</span> <span property="familyName">Butt</span>, <span property="honorificSuffix">M.B., B.S.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1118-1826" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1118-1826</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mohamed H.</span> <span property="familyName">Al-Thani</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Abdullatif</span> <span property="familyName">Al Khal</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Roberto</span> <span property="familyName">Bertollini</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span></span>, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Laith J.</span> <span property="familyName">Abu-Raddad</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0790-0506" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-0790-0506</a></span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">-16</span></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">October 6, 2021</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2021<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">385</span></span>: <span property="identifier" typeof="Text">e83</span></div><div class="doi">DOI: 10.1056/NEJMoa2114114</div><div class="core-enumeration"><a href="/toc/nejm/385/24"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">385</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">24</span></span></a></div><div><a href="#tab-information">Copyright © 2021</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DHiam%2BChemaitelly%252C%2BPatrick%2BTang%252C%2BMohammad%2BR.%2BHasan%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D385%26issueNum%3D24%26contentID%3D10.1056%252FNEJMoa2114114%26title%3DWaning%2Bof%2BBNT162b2%2BVaccine%2BProtection%2Bagainst%2BSARS-CoV-2%2BInfection%2Bin%2BQatar%26publicationDate%3D12%252F09%252F2021" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2114114" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DHiam%2BChemaitelly%252C%2BPatrick%2BTang%252C%2BMohammad%2BR.%2BHasan%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D385%26issueNum%3D24%26contentID%3D10.1056%252FNEJMoa2114114%26title%3DWaning%2Bof%2BBNT162b2%2BVaccine%2BProtection%2Bagainst%2BSARS-CoV-2%2BInfection%2Bin%2BQatar%26publicationDate%3D12%252F09%252F2021" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/788246f4-ec9f-4d5b-a537-a7b26a9b7eac/nejmoa2114114.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2114114.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2114114" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2114114" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2114114.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">Waning of vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The persistence of BNT162b2 (Pfizer–BioNTech) vaccine effectiveness against infection and disease in Qatar, where the B.1.351 (or beta) and B.1.617.2 (or delta) variants have dominated incidence and polymerase-chain-reaction testing is done on a mass scale, is unclear.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We used a matched test-negative, case–control study design to estimate vaccine effectiveness against any SARS-CoV-2 infection and against any severe, critical, or fatal case of Covid-19, from January 1 to September 5, 2021.</div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">Estimated BNT162b2 effectiveness against any SARS-CoV-2 infection was negligible in the first 2 weeks after the first dose. It increased to 36.8% (95% confidence interval [CI], 33.2 to 40.2) in the third week after the first dose and reached its peak at 77.5% (95% CI, 76.4 to 78.6) in the first month after the second dose. Effectiveness declined gradually thereafter, with the decline accelerating after the fourth month to reach approximately 20% in months 5 through 7 after the second dose. Effectiveness against symptomatic infection was higher than effectiveness against asymptomatic infection but waned similarly. Variant-specific effectiveness waned in the same pattern. Effectiveness against any severe, critical, or fatal case of Covid-19 increased rapidly to 66.1% (95% CI, 56.8 to 73.5) by the third week after the first dose and reached 96% or higher in the first 2 months after the second dose; effectiveness persisted at approximately this level for 6 months.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">BNT162b2-induced protection against SARS-CoV-2 infection appeared to wane rapidly following its peak after the second dose, but protection against hospitalization and death persisted at a robust level for 6 months after the second dose. (Funded by Weill Cornell Medicine–Qatar and others.)</div></section></section></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">Qatar launched a mass coronavirus disease 2019 (Covid-19) immunization campaign on December 21, 2020, first using the BNT162b2<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-1" href-manipulated="true" aria-label="Reference 1">1</a></sup> (Pfizer–BioNTech) messenger RNA (mRNA) vaccine<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2-1" href-manipulated="true" aria-label="Reference 2">2</a></sup> and 3 months later adding the mRNA-1273<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-1" href-manipulated="true" aria-label="Reference 3">3</a></sup> (Moderna) vaccine.<sup><a href="#core-r4" role="doc-biblioref" data-xml-rid="r4" id="body-ref-r4-1" href-manipulated="true" aria-label="Reference 4">4</a></sup> Immunization with both vaccines followed the Food and Drug Administration–approved protocol,<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1 r3" id="body-ref-r3-2" href-manipulated="true">1,3</a></sup> and vaccine coverage increased steadily from December 2020 until the time of this writing (<a href="#f1">Figure 1A</a>). Vaccine rollout proceeded in phases in which vaccination was prioritized first to frontline health care workers, persons with severe or multiple chronic conditions, and persons 70 years of age or older. Vaccination was then gradually extended by one age group at a time and to select professional groups (e.g., teachers), with age being the principal criterion for vaccine eligibility throughout the rollout (Fig. S1A in the <a href="#ap1">Supplementary Appendix</a>, available with the full text of this article at NEJM.org). As of September 7, 2021, it was estimated that at least 90% of persons 12 years of age or older had received at least one vaccine dose and that at least 80% had received both doses.<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5" id="body-ref-r5-1" href-manipulated="true" aria-label="Reference 5">5</a></sup> This appeared to be the highest mRNA vaccine coverage worldwide.<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6" href-manipulated="true" aria-label="Reference 6">6</a></sup></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f1.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/21755fa7-b76f-4b1d-a183-00d2ea09ea80/assets/images/large/nejmoa2114114_f1.jpg" height="3438" width="2315" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Time Trend of Vaccinated Persons, SARS-CoV-2 Infections, and Vaccine Breakthrough Infections in Qatar.</div><div class="notes"><div role="doc-footnote">SARS-CoV-2 denotes severe acute respiratory syndrome coronavirus 2.</div></div></figcaption></figure></div><div role="paragraph">As vaccination was scaled up, the country had two back-to-back waves of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from January through June 2021, which were dominated by the B.1.1.7 (or alpha)<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7" id="body-ref-r7-1" href-manipulated="true" aria-label="Reference 7">7</a></sup> and B.1.351 (or beta)<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7" id="body-ref-r7-2" href-manipulated="true" aria-label="Reference 7">7</a></sup> variants.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r4 r8 r9 r10" id="body-ref-r10-1" href-manipulated="true">2,4,8–10</a></sup> Appreciable community transmission of the B.1.617.2 (or delta)<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7" id="body-ref-r7-3" href-manipulated="true" aria-label="Reference 7">7</a></sup> variant was first detected toward the end of March 2021; by the summer of 2021, B.1.617.2 had become the dominant variant.<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8 r9 r10" id="body-ref-r10-2" href-manipulated="true">8-10</a></sup> Despite the high vaccine coverage, the incidence of SARS-CoV-2 infection increased slowly from July to August 2021, before starting to decline at the end of August (<a href="#f1">Figure 1B</a>). In this study, we assessed the real-world effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection and Covid-19–related hospitalization and death after receipt of the first and second doses.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Study Population, Data Sources, and Study Design</h3><div role="paragraph">This study was conducted in the resident population of Qatar. Covid-19 laboratory testing, vaccination, clinical infection data, and related demographic details were extracted from the integrated, nationwide, digital health information platform that hosts the national, federated SARS-CoV-2 databases. These databases are complete, with no missing information for polymerase-chain-reaction (PCR) testing, Covid-19 vaccinations, Covid-19–related hospitalizations, or basic demographic details since the start of the epidemic.</div><div role="paragraph">Vaccine effectiveness against SARS-CoV-2 infection was estimated with the use of the test-negative, case–control study design, a standard design for assessing vaccine effectiveness against influenza<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-1" href-manipulated="true">11,12</a></sup> and SARS-CoV-2.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r4 r11 r12 r13 r14 r15 r16" id="body-ref-r16" href-manipulated="true">2,4,11–16</a></sup> Key to this design is its control of bias arising from misclassification of infection and differences in health care–seeking behavior between vaccinated and unvaccinated persons.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-3" href-manipulated="true">11,12</a></sup> Case participants (PCR-positive persons) and controls (PCR-negative persons) were matched one to one according to sex, 10-year age group, nationality, reason for SARS-CoV-2 PCR testing, and calendar week of PCR test. Matching of case participants and controls was performed to control for known differences in the risk of exposure to SARS-CoV-2 infection in Qatar.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r18 r19 r20" id="body-ref-r20-1" href-manipulated="true">17-20</a></sup></div><div role="paragraph">Effectiveness was estimated against documented infection (defined as a PCR-positive swab, regardless of the reason for PCR testing or the presence of symptoms), as well as against any severe,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-1" href-manipulated="true" aria-label="Reference 21">21</a></sup> critical,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-2" href-manipulated="true" aria-label="Reference 21">21</a></sup> or fatal<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="body-ref-r22-1" href-manipulated="true" aria-label="Reference 22">22</a></sup> case of Covid-19. Classification of Covid-19 case severity (acute-care hospitalizations),<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-3" href-manipulated="true" aria-label="Reference 21">21</a></sup> criticality (intensive care unit hospitalizations),<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-4" href-manipulated="true" aria-label="Reference 21">21</a></sup> and fatality<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="body-ref-r22-2" href-manipulated="true" aria-label="Reference 22">22</a></sup> was conducted in accordance with World Health Organization guidelines, and assessments were made by trained medical personnel with the use of individual chart reviews. (Details are provided in Sections 1 and 2 in the <a href="#ap1">Supplementary Appendix</a>.)</div><div role="paragraph">The study was approved by the institutional review boards at Hamad Medical Corporation and Weill Cornell Medicine–Qatar, with waiver of informed consent. Reporting of the study followed Strengthening the Reporting of Observational Studies in Epidemiology guidelines (Table S1). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or the writing of the article.</div></section><section id="sec-1-2"><h3>Laboratory Methods and Classification of Infections</h3><div role="paragraph">Details regarding laboratory methods for reverse-transcriptase–quantitative PCR (RT-qPCR) testing are provided in Section 3 in the <a href="#ap1">Supplementary Appendix</a>. Methods for classification of infections according to variant type with the use of RT-qPCR variant screening<sup><a href="#core-r23" role="doc-biblioref" data-xml-rid="r23" id="body-ref-r23" href-manipulated="true" aria-label="Reference 23">23</a></sup> of random positive clinical samples<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8 r10" id="body-ref-r10-3" href-manipulated="true">8,10</a></sup> are provided in Section 4 in the <a href="#ap1">Supplementary Appendix</a>.</div></section><section id="sec-1-3"><h3>Statistical Analysis</h3><div role="paragraph">Sociodemographic characteristics of study samples were described with the use of frequency distributions and measures of central tendency. The odds ratio, comparing odds of vaccination among case participants and controls, and its associated 95% confidence interval were derived with the use of conditional logistic regression that accounted for the matching in the study design. This matching and analysis approach aims to minimize the potential bias that may result from variation in epidemic phase,<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r24" id="body-ref-r24-1" href-manipulated="true">11,24</a></sup> gradual rollout of vaccination during the study,<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r24" id="body-ref-r24-2" href-manipulated="true">11,24</a></sup> or other confounders.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r18 r19 r20 r25 r26" id="body-ref-r26" href-manipulated="true">17–20,25,26</a></sup> Confidence intervals were not adjusted for multiplicity. Interactions were not investigated. Vaccine effectiveness at different time points and the associated 95% confidence interval were then calculated by applying the following equation<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-4" href-manipulated="true">11,12</a></sup>: vaccine effectiveness=1−odds ratio of vaccination among case participants as compared with controls. Details regarding the statistical analysis are provided in Section 1 in the <a href="#ap1">Supplementary Appendix</a>.</div><div role="paragraph">A sensitivity analysis was conducted by adjusting the conditional logistic regression for previous infection and health care worker status, because health care workers were prioritized for vaccination and may have had a higher risk of infection exposure. Several additional sensitivity analyses were conducted by modifying the study inclusion and exclusion criteria to investigate whether the effectiveness estimates could have been biased. Effectiveness was also estimated with the use of a multivariable logistic-regression analysis of associations with a PCR-positive test — that is, by applying a different method from that of the main analysis of matched test-negative, case–control study design. Descriptions of these sensitivity analyses are provided in Section 5 in the <a href="#ap1">Supplementary Appendix</a>. Statistical analyses were conducted with the use of STATA/SE software, version 17.0.<sup><a href="#core-r27" role="doc-biblioref" data-xml-rid="r27" id="body-ref-r27" href-manipulated="true" aria-label="Reference 27">27</a></sup></div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Study Population</h3><div role="paragraph">Between December 21, 2020, and September 5, 2021, a total of 947,035 persons received at least one dose of BNT162b2, and 907,763 completed the two-dose regimen (<a href="#f1">Figure 1A</a>). The median date of the first dose was April 21, 2021, and the median date of the second dose was May 10, 2021. The median time between the first and second doses was 21 days (interquartile range, 21 to 22 days), and 97.4% of persons received their second dose within 30 days after the first dose. During this period, 564,196 persons received at least one dose of mRNA-1273, and 494,859 completed the two-dose regimen (<a href="#f1">Figure 1A</a>).</div><div role="paragraph">Figure S2 shows the population-selection process used to investigate BNT162b2 effectiveness against SARS-CoV-2 infection. The distribution of included PCR-positive case participants according to calendar month is shown in Figure S1B. Demographic characteristics and reasons for PCR testing of samples used to estimate vaccine effectiveness are presented in <a href="#t1">Table 1</a> and Tables S2 and S3. The median age of the study participants was 31 years, approximately 69% were male, and participants came from diverse national origins. Study samples were representative of the distinct demographic characteristics of the population of Qatar.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r28" id="body-ref-r28-1" href-manipulated="true">17,28</a></sup></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/2d422ab1-a140-4299-8a82-3b4f1ef4e059/assets/images/large/nejmoa2114114_t1.jpg" height="2322" width="2615" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Characteristics</th><th class="txxx-borders" colspan="2"><span>0–13 Days after First Dose</span></th><th class="txxx-borders" colspan="2"><span>≥14 Days after First Dose and No Second Dose</span></th><th class="txxr-borders" colspan="2"><span>First Month after Second Dose</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Case Participants:<br>PCR-Positive<br>(N=115,326)</th><th class="xxxx-borders">Controls:<br>PCR-Negative<br>(N=115,326)</th><th class="xxxx-borders">Case Participants:<br>PCR-Positive<br>(N=113,830)</th><th class="xxxx-borders">Controls:<br>PCR-Negative<br>(N=113,830)</th><th class="xxxx-borders">Case Participants:<br>PCR-Positive<br>(N=115,913)</th><th class="xxxr-borders">Controls:<br>PCR-Negative<br>(N=115,913)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Median age (IQR) — yr</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxr-borders shading">31 (22–39)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Age group — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">&lt;20 yr</td><td class="xxxx-borders shading">26,915 (23.3)</td><td class="xxxx-borders shading">26,915 (23.3)</td><td class="xxxx-borders shading">26,813 (23.6)</td><td class="xxxx-borders shading">26,813 (23.6)</td><td class="xxxx-borders shading">26,822 (23.1)</td><td class="xxxr-borders shading">26,822 (23.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">20–29 yr</td><td class="xxxx-borders">24,879 (21.6)</td><td class="xxxx-borders">24,879 (21.6)</td><td class="xxxx-borders">24,567 (21.6)</td><td class="xxxx-borders">24,567 (21.6)</td><td class="xxxx-borders">24,770 (21.4)</td><td class="xxxr-borders">24,770 (21.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">30–39 yr</td><td class="xxxx-borders shading">36,749 (31.9)</td><td class="xxxx-borders shading">36,749 (31.9)</td><td class="xxxx-borders shading">36,150 (31.8)</td><td class="xxxx-borders shading">36,150 (31.8)</td><td class="xxxx-borders shading">36,896 (31.8)</td><td class="xxxr-borders shading">36,896 (31.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">40–49 yr</td><td class="xxxx-borders">19,154 (16.6)</td><td class="xxxx-borders">19,154 (16.6)</td><td class="xxxx-borders">18,820 (16.5)</td><td class="xxxx-borders">18,820 (16.5)</td><td class="xxxx-borders">19,382 (16.7)</td><td class="xxxr-borders">19,382 (16.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">50–59 yr</td><td class="xxxx-borders shading">6,083 (5.3)</td><td class="xxxx-borders shading">6,083 (5.3)</td><td class="xxxx-borders shading">5,959 (5.2)</td><td class="xxxx-borders shading">5,959 (5.2)</td><td class="xxxx-borders shading">6,350 (5.5)</td><td class="xxxr-borders shading">6,350 (5.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">60–69 yr</td><td class="xxxx-borders">1,229 (1.1)</td><td class="xxxx-borders">1,229 (1.1)</td><td class="xxxx-borders">1,195 (1.0)</td><td class="xxxx-borders">1,195 (1.0)</td><td class="xxxx-borders">1,326 (1.1)</td><td class="xxxr-borders">1,326 (1.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">≥70 yr</td><td class="xxxx-borders shading">317 (0.3)</td><td class="xxxx-borders shading">317 (0.3)</td><td class="xxxx-borders shading">326 (0.3)</td><td class="xxxx-borders shading">326 (0.3)</td><td class="xxxx-borders shading">367 (0.3)</td><td class="xxxr-borders shading">367 (0.3)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Sex</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Male</td><td class="xxxx-borders shading">79,255 (68.7)</td><td class="xxxx-borders shading">79,255 (68.7)</td><td class="xxxx-borders shading">78,148 (68.7)</td><td class="xxxx-borders shading">78,148 (68.7)</td><td class="xxxx-borders shading">79,750 (68.8)</td><td class="xxxr-borders shading">79,750 (68.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Female</td><td class="xxxx-borders">36,071 (31.3)</td><td class="xxxx-borders">36,071 (31.3)</td><td class="xxxx-borders">35,682 (31.3)</td><td class="xxxx-borders">35,682 (31.3)</td><td class="xxxx-borders">36,163 (31.2)</td><td class="xxxr-borders">36,163 (31.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Nationality<a href="#t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Bangladeshi</td><td class="xxxx-borders">8,323 (7.2)</td><td class="xxxx-borders">8,323 (7.2)</td><td class="xxxx-borders">8,229 (7.2)</td><td class="xxxx-borders">8,229 (7.2)</td><td class="xxxx-borders">8,326 (7.2)</td><td class="xxxr-borders">8,326 (7.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Egyptian</td><td class="xxxx-borders shading">6,734 (5.8)</td><td class="xxxx-borders shading">6,734 (5.8)</td><td class="xxxx-borders shading">6,629 (5.8)</td><td class="xxxx-borders shading">6,629 (5.8)</td><td class="xxxx-borders shading">6,859 (5.9)</td><td class="xxxr-borders shading">6,859 (5.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Filipino</td><td class="xxxx-borders">10,713 (9.3)</td><td class="xxxx-borders">10,713 (9.3)</td><td class="xxxx-borders">10,535 (9.3)</td><td class="xxxx-borders">10,535 (9.3)</td><td class="xxxx-borders">10,674 (9.2)</td><td class="xxxr-borders">10,674 (9.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Indian</td><td class="xxxx-borders shading">29,914 (25.9)</td><td class="xxxx-borders shading">29,914 (25.9)</td><td class="xxxx-borders shading">29,536 (25.9)</td><td class="xxxx-borders shading">29,536 (25.9)</td><td class="xxxx-borders shading">30,325 (26.2)</td><td class="xxxr-borders shading">30,325 (26.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Nepalese</td><td class="xxxx-borders">10,505 (9.1)</td><td class="xxxx-borders">10,505 (9.1)</td><td class="xxxx-borders">10,367 (9.1)</td><td class="xxxx-borders">10,367 (9.1)</td><td class="xxxx-borders">10,496 (9.1)</td><td class="xxxr-borders">10,496 (9.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Pakistani</td><td class="xxxx-borders shading">5,793 (5.0)</td><td class="xxxx-borders shading">5,793 (5.0)</td><td class="xxxx-borders shading">5,735 (5.0)</td><td class="xxxx-borders shading">5,735 (5.0)</td><td class="xxxx-borders shading">5,837 (5.0)</td><td class="xxxr-borders shading">5,837 (5.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Qatari</td><td class="xxxx-borders">17,375 (15.1)</td><td class="xxxx-borders">17,375 (15.1)</td><td class="xxxx-borders">17,087 (15.0)</td><td class="xxxx-borders">17,087 (15.0)</td><td class="xxxx-borders">17,147 (14.8)</td><td class="xxxr-borders">17,147 (14.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Sri Lankan</td><td class="xxxx-borders shading">3,756 (3.3)</td><td class="xxxx-borders shading">3,756 (3.3)</td><td class="xxxx-borders shading">3,732 (3.3)</td><td class="xxxx-borders shading">3,732 (3.3)</td><td class="xxxx-borders shading">3,784 (3.3)</td><td class="xxxr-borders shading">3,784 (3.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Sudanese</td><td class="xxxx-borders">3,249 (2.8)</td><td class="xxxx-borders">3,249 (2.8)</td><td class="xxxx-borders">3,242 (2.8)</td><td class="xxxx-borders">3,242 (2.8)</td><td class="xxxx-borders">3,285 (2.8)</td><td class="xxxr-borders">3,285 (2.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Other nationalities<a href="#t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders shading">18,964 (16.4)</td><td class="xxxx-borders shading">18,964 (16.4)</td><td class="xxxx-borders shading">18,738 (16.5)</td><td class="xxxx-borders shading">18,738 (16.5)</td><td class="xxxx-borders shading">19,180 (16.5)</td><td class="xxxr-borders shading">19,180 (16.5)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Reason for PCR testing</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Clinical suspicion</td><td class="xxxx-borders shading">40,768 (35.4)</td><td class="xxxx-borders shading">40,768 (35.4)</td><td class="xxxx-borders shading">40,261 (35.4)</td><td class="xxxx-borders shading">40,261 (35.4)</td><td class="xxxx-borders shading">41,138 (35.5)</td><td class="xxxr-borders shading">41,138 (35.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Contact tracing</td><td class="xxxx-borders">18,772 (16.3)</td><td class="xxxx-borders">18,772 (16.3)</td><td class="xxxx-borders">18,481 (16.2)</td><td class="xxxx-borders">18,481 (16.2)</td><td class="xxxx-borders">18,666 (16.1)</td><td class="xxxr-borders">18,666 (16.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Routine health care testing</td><td class="xxxx-borders shading">14,479 (12.6)</td><td class="xxxx-borders shading">14,479 (12.6)</td><td class="xxxx-borders shading">14,351 (12.6)</td><td class="xxxx-borders shading">14,351 (12.6)</td><td class="xxxx-borders shading">14,536 (12.5)</td><td class="xxxr-borders shading">14,536 (12.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Survey</td><td class="xxxx-borders">27,972 (24.3)</td><td class="xxxx-borders">27,972 (24.3)</td><td class="xxxx-borders">27,484 (24.1)</td><td class="xxxx-borders">27,484 (24.1)</td><td class="xxxx-borders">27,883 (24.1)</td><td class="xxxr-borders">27,883 (24.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Individual request</td><td class="xxxx-borders shading">12,914 (11.2)</td><td class="xxxx-borders shading">12,914 (11.2)</td><td class="xxxx-borders shading">12,838 (11.3)</td><td class="xxxx-borders shading">12,838 (11.3)</td><td class="xxxx-borders shading">13,233 (11.4)</td><td class="xxxr-borders shading">13,233 (11.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">Other</td><td class="xbxx-borders">421 (0.4)</td><td class="xbxx-borders">421 (0.4)</td><td class="xbxx-borders">415 (0.4)</td><td class="xbxx-borders">415 (0.4)</td><td class="xbxx-borders">457 (0.4)</td><td class="xbxr-borders">457 (0.4)</td></tr></tbody></table></div><figcaption><div class="caption">Demographic Characteristics of the Participants and Reasons for PCR Testing among Samples Used to Estimate BNT162b2 Vaccine Effectiveness.<a href="#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">Data for other time-since-vaccination analyses are shown in Tables S2 and S3 in the <a href="#ap1">Supplementary Appendix</a>. Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for polymerase-chain-reaction (PCR) testing, and calendar week of PCR test. Percentages may not total 100 because of rounding. IQR denotes interquartile range.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t1fn2" role="paragraph">Nationalities were chosen to represent the most populous groups in Qatar.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t1fn3" role="paragraph">The category of other nationalities includes 108 other nationalities in Qatar for 0 to 13 days after the first dose, 106 other nationalities for 14 or more days after the first dose and no second dose, and 108 other nationalities for the first month after the second dose.</div></div></div></figcaption></figure></div><div role="paragraph">Only approximately 35% of case participants received a diagnosis of SARS-CoV-2 infection on the basis of symptoms (<a href="#t1">Table 1</a>). The remaining case participants received a diagnosis on the basis of PCR testing for other reasons, including contact tracing, surveys or random testing campaigns, individual requests, and routine health care testing.</div></section><section id="sec-2-2"><h3>Vaccine Breakthrough Infections</h3><div role="paragraph">As of the end of the study (September 5, 2021), a total of 8203 SARS-CoV-2 BNT162b2 breakthrough infections had been recorded among participants who received one dose of this vaccine, and 10,543 such infections had been recorded among participants who received two doses. The percentage of all daily diagnosed SARS-CoV-2 infections that were vaccine (BNT162b2 or mRNA-1273) breakthrough infections increased gradually over time and reached 36.4% on September 5, 2021 (<a href="#f1">Figure 1C</a>). Most vaccine breakthrough infections (77.2%) were recorded for the BNT162b2 vaccine.</div><div role="paragraph">As of August 30, 2021, a total of 377 and 106 severe Covid-19 cases (acute-care hospitalizations<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-5" href-manipulated="true" aria-label="Reference 21">21</a></sup>) had been recorded among participants who had received either one or two doses of BNT162b2, respectively. Similarly, 32 and 10 critical Covid-19 cases (ICU hospitalizations<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-6" href-manipulated="true" aria-label="Reference 21">21</a></sup>) and 34 and 15 fatal Covid-19 cases (Covid-19–related deaths<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="body-ref-r22-3" href-manipulated="true" aria-label="Reference 22">22</a></sup>) had also been recorded, respectively. Details are provided in Section 2 in the <a href="#ap1">Supplementary Appendix</a>.</div></section><section id="sec-2-3"><h3>Vaccine Effectiveness against Any SARS-CoV-2 Infection</h3><div role="paragraph">Estimated BNT162b2 effectiveness against any SARS-CoV-2 infection was negligible for the first 2 weeks after the first dose, increased to 36.8% (95% confidence interval [CI], 33.2 to 40.2) in the third week after the first dose, and reached its peak at 77.5% (95% CI, 76.4 to 78.6) in the first month after the second dose (<a href="#t2">Table 2</a> and <a href="#f2">Figure 2A</a>). However, effectiveness declined gradually, starting from the first month after the second dose. The decline accelerated after the fourth month, and effectiveness reached a low level of approximately 20% in months 5 through 7 after the second dose. A sensitivity analysis that adjusted for previous infection and health care worker status confirmed the main analysis results (<a href="#t3">Table 3</a>).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f2.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/d0c3ffb2-c5cc-4dc7-9cf2-68d68a8a241e/assets/images/large/nejmoa2114114_f2.jpg" height="3037" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine.</div><div class="notes"><div role="doc-footnote">Data are presented as effectiveness point estimates, with 𝙸 bars indicating the corresponding 95% confidence intervals. Covid-19 denotes coronavirus disease 2019.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 2</div><nav><a href="#t2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t2" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/7d8ee96f-212b-49bc-bec9-1906762e27e7/assets/images/large/nejmoa2114114_t2.jpg" height="1694" width="2615" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Substudies<a href="#t2fn2" role="doc-noteref">†</a></th><th class="txxx-borders" colspan="5"><span>Effectiveness against Infection</span></th><th class="txxr-borders" colspan="5"><span>Effectiveness against Hospitalization and Death</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#t2fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#t2fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders">Effectiveness % (95% CI)<a href="#t2fn4" role="doc-noteref">§</a></th><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>Severe, Critical, or Fatal Disease<a href="#t2fn3" role="doc-noteref">‡</a><a href="#t2fn5" role="doc-noteref">¶</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#t2fn3" role="doc-noteref">‡</a></span></th><th class="xxxr-borders">Effectiveness % (95% CI)<a href="#t2fn4" role="doc-noteref">§</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">0–13 Days after first dose</td><td class="xxxx-borders shading">4228</td><td class="xxxx-borders shading">111,098</td><td class="xxxx-borders shading">4053</td><td class="xxxx-borders shading">111,273</td><td class="xxxx-borders shading">−4.9<br>(−9.8 to −0.2)</td><td class="xxxx-borders shading">245</td><td class="xxxx-borders shading">4001</td><td class="xxxx-borders shading">286</td><td class="xxxx-borders shading">3960</td><td class="xxxr-borders shading">16.1<br>(−0.6 to 30.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">≥14 Days after first dose and no second dose</td><td class="xxxx-borders">2358</td><td class="xxxx-borders">111,472</td><td class="xxxx-borders">3567</td><td class="xxxx-borders">110,263</td><td class="xxxx-borders">36.8<br>(33.2 to 40.2)</td><td class="xxxx-borders">102</td><td class="xxxx-borders">4032</td><td class="xxxx-borders">272</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">66.1<br>(56.8 to 73.5)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Month after second dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">1</td><td class="xxxx-borders">2915</td><td class="xxxx-borders">112,998</td><td class="xxxx-borders">9986</td><td class="xxxx-borders">105,927</td><td class="xxxx-borders">77.5<br>(76.4 to 78.6)</td><td class="xxxx-borders">32</td><td class="xxxx-borders">4082</td><td class="xxxx-borders">585</td><td class="xxxx-borders">3529</td><td class="xxxr-borders">96.0<br>(93.9 to 97.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">2</td><td class="xxxx-borders shading">1450</td><td class="xxxx-borders shading">111,874</td><td class="xxxx-borders shading">4304</td><td class="xxxx-borders shading">109,020</td><td class="xxxx-borders shading">73.2<br>(71.3 to 75.0)</td><td class="xxxx-borders shading">23</td><td class="xxxx-borders shading">4062</td><td class="xxxx-borders shading">323</td><td class="xxxx-borders shading">3762</td><td class="xxxr-borders shading">96.8<br>(93.9 to 98.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">3</td><td class="xxxx-borders">800</td><td class="xxxx-borders">111,388</td><td class="xxxx-borders">2128</td><td class="xxxx-borders">110,060</td><td class="xxxx-borders">69.6<br>(66.7 to 72.3)</td><td class="xxxx-borders">17</td><td class="xxxx-borders">4026</td><td class="xxxx-borders">181</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">94.3<br>(89.1 to 97.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">4</td><td class="xxxx-borders shading">492</td><td class="xxxx-borders shading">111,070</td><td class="xxxx-borders shading">856</td><td class="xxxx-borders shading">110,706</td><td class="xxxx-borders shading">51.7<br>(45.0 to 57.6)</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">3996</td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">3955</td><td class="xxxr-borders shading">83.7<br>(65.5 to 92.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">5</td><td class="xxxx-borders">548</td><td class="xxxx-borders">110,991</td><td class="xxxx-borders">646</td><td class="xxxx-borders">110,893</td><td class="xxxx-borders">22.5<br>(10.6 to 32.7)</td><td class="xxxx-borders">0</td><td class="xxxx-borders">3990</td><td class="xxxx-borders">33</td><td class="xxxx-borders">3957</td><td class="xxxr-borders">100.0<a href="#t2fn6" role="doc-noteref">‖</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">6</td><td class="xxxx-borders shading">460</td><td class="xxxx-borders shading">111,007</td><td class="xxxx-borders shading">512</td><td class="xxxx-borders shading">110,955</td><td class="xxxx-borders shading">17.3<br>(2.2 to 30.1)</td><td class="xxxx-borders shading">8</td><td class="xxxx-borders shading">3988</td><td class="xxxx-borders shading">24</td><td class="xxxx-borders shading">3972</td><td class="xxxr-borders shading">88.9<br>(52.1 to 97.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">≥7</td><td class="xbxx-borders">135</td><td class="xbxx-borders">110,942</td><td class="xbxx-borders">162</td><td class="xbxx-borders">110,915</td><td class="xbxx-borders">22.3<br>(−1.7 to 40.7)</td><td class="xbxx-borders">6</td><td class="xbxx-borders">3983</td><td class="xbxx-borders">11</td><td class="xbxx-borders">3978</td><td class="xbxr-borders">55.6<br>(−44.3 to 86.3)</td></tr></tbody></table></div><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine against Any SARS-CoV-2 Infection and against Any Severe, Critical, or Fatal Case of Covid-19.<a href="#t2fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t2fn1" role="paragraph">Covid-19 denotes coronavirus disease 2019, and SARS-CoV-2 severe acute respiratory syndrome coronavirus 2.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t2fn2" role="paragraph">In each analysis for a specific time-since-vaccination stratum, we included only participants vaccinated in this specific time-since-vaccination stratum and those unvaccinated. Only matched pairs of PCR-positive and PCR-negative persons, in which both members of the pair were either unvaccinated or fell within each time-since-vaccination stratum, were included in the corresponding estimate of vaccine effectiveness. Thus, the number of case participants (and controls) varied across time-since-vaccination analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t2fn3" role="paragraph">Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for PCR testing, and calendar week of PCR test.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="t2fn4" role="paragraph">Vaccine effectiveness was estimated with the use of the test-negative, case–control study design.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-5" href-manipulated="true">11,12</a></sup></div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="t2fn5" role="paragraph">Severity,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-7" href-manipulated="true" aria-label="Reference 21">21</a></sup> criticality,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-8" href-manipulated="true" aria-label="Reference 21">21</a></sup> and fatality<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="body-ref-r22-4" href-manipulated="true" aria-label="Reference 22">22</a></sup> were defined according to World Health Organization guidelines.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="t2fn6" role="paragraph">The confidence interval could not be estimated because there were zero events among vaccinated participants.</div></div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 3</div><nav><a href="#t3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t3" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t3" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/7ed1a812-a7da-4aea-af43-8a51d53b4980/assets/images/large/nejmoa2114114_t3.jpg" height="1732" width="2615" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Substudies<a href="#t3fn2" role="doc-noteref">†</a></th><th class="txxx-borders" colspan="5"><span>Effectiveness against Infection</span></th><th class="txxr-borders" colspan="5"><span>Effectiveness against Hospitalization and Death</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#t3fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#t3fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders">Effectiveness % (95% CI)<a href="#t3fn4" role="doc-noteref">§</a></th><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>Severe, Critical, or Fatal Disease<a href="#t3fn3" role="doc-noteref">‡</a><a href="#t3fn5" role="doc-noteref">¶</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#t3fn3" role="doc-noteref">‡</a></span></th><th class="xxxr-borders">Effectiveness % (95% CI)<a href="#t3fn4" role="doc-noteref">§</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">0–13 Days after first dose</td><td class="xxxx-borders shading">4228</td><td class="xxxx-borders shading">111,098</td><td class="xxxx-borders shading">4053</td><td class="xxxx-borders shading">111,273</td><td class="xxxx-borders shading">−11.9<br>(−17.3 to −6.7)</td><td class="xxxx-borders shading">245</td><td class="xxxx-borders shading">4001</td><td class="xxxx-borders shading">286</td><td class="xxxx-borders shading">3960</td><td class="xxxr-borders shading">7.5<br>(−11.9 to 23.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">≥14 Days after first dose and no second dose</td><td class="xxxx-borders">2358</td><td class="xxxx-borders">111,472</td><td class="xxxx-borders">3567</td><td class="xxxx-borders">110,263</td><td class="xxxx-borders">32.2<br>(28.2 to 35.9)</td><td class="xxxx-borders">102</td><td class="xxxx-borders">4032</td><td class="xxxx-borders">272</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">65.0<br>(55.0 to 72.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Month after second dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">1</td><td class="xxxx-borders">2915</td><td class="xxxx-borders">112,998</td><td class="xxxx-borders">9986</td><td class="xxxx-borders">105,927</td><td class="xxxx-borders">75.8<br>(74.6 to 77.0)</td><td class="xxxx-borders">32</td><td class="xxxx-borders">4082</td><td class="xxxx-borders">585</td><td class="xxxx-borders">3529</td><td class="xxxr-borders">95.9<br>(93.6 to 97.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">2</td><td class="xxxx-borders shading">1450</td><td class="xxxx-borders shading">111,874</td><td class="xxxx-borders shading">4304</td><td class="xxxx-borders shading">109,020</td><td class="xxxx-borders shading">69.7<br>(67.4 to 71.8)</td><td class="xxxx-borders shading">23</td><td class="xxxx-borders shading">4062</td><td class="xxxx-borders shading">323</td><td class="xxxx-borders shading">3762</td><td class="xxxr-borders shading">96.3<br>(92.9 to 98.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">3</td><td class="xxxx-borders">800</td><td class="xxxx-borders">111,388</td><td class="xxxx-borders">2128</td><td class="xxxx-borders">110,060</td><td class="xxxx-borders">63.7<br>(59.9 to 67.1)</td><td class="xxxx-borders">17</td><td class="xxxx-borders">4026</td><td class="xxxx-borders">181</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">93.4<br>(87.5 to 96.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">4</td><td class="xxxx-borders shading">492</td><td class="xxxx-borders shading">111,070</td><td class="xxxx-borders shading">856</td><td class="xxxx-borders shading">110,706</td><td class="xxxx-borders shading">39.1<br>(29.9 to 47.0)</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">3996</td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">3955</td><td class="xxxr-borders shading">80.8<br>(56.9 to 91.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">5</td><td class="xxxx-borders">548</td><td class="xxxx-borders">110,991</td><td class="xxxx-borders">646</td><td class="xxxx-borders">110,893</td><td class="xxxx-borders">11.4<br>(−3.5 to 24.1)</td><td class="xxxx-borders">0</td><td class="xxxx-borders">3990</td><td class="xxxx-borders">33</td><td class="xxxx-borders">3957</td><td class="xxxr-borders">100.0<a href="#t3fn6" role="doc-noteref">‖</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">6</td><td class="xxxx-borders shading">460</td><td class="xxxx-borders shading">111,007</td><td class="xxxx-borders shading">512</td><td class="xxxx-borders shading">110,955</td><td class="xxxx-borders shading">9.2<br>(−9.1 to 24.5)</td><td class="xxxx-borders shading">8</td><td class="xxxx-borders shading">3988</td><td class="xxxx-borders shading">24</td><td class="xxxx-borders shading">3972</td><td class="xxxr-borders shading">81.8<br>(18.5 to 95.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">≥7</td><td class="xbxx-borders">135</td><td class="xbxx-borders">110,942</td><td class="xbxx-borders">162</td><td class="xbxx-borders">110,915</td><td class="xbxx-borders">−4.4<br>(−41.3 to 22.9)</td><td class="xbxx-borders">6</td><td class="xbxx-borders">3983</td><td class="xbxx-borders">11</td><td class="xbxx-borders">3978</td><td class="xbxr-borders">44.1<br>(−86.5 to 83.3)</td></tr></tbody></table></div><figcaption><div class="caption">Sensitivity Analysis.<a href="#t3fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t3fn1" role="paragraph">Shown is the effectiveness of the BNT162b2 vaccine against any SARS-CoV-2 infection and against any severe, critical, or fatal case of COVID-19 after adjustment for previous infection and health care worker status.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t3fn2" role="paragraph">In each analysis for a specific time-since-vaccination stratum, we included only participants vaccinated in this specific time-since-vaccination stratum and those unvaccinated. Only matched pairs of PCR-positive and PCR-negative persons, in which both members of the pair were either unvaccinated or fell within each time-since-vaccination stratum, were included in the corresponding estimate of vaccine effectiveness. Thus, the number of case participants (and controls) varied across time-since-vaccination analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t3fn3" role="paragraph">Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for PCR testing, and calendar week of PCR test.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="t3fn4" role="paragraph">Vaccine effectiveness was estimated with the use of the test-negative, case–control study design.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-6" href-manipulated="true">11,12</a></sup></div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="t3fn5" role="paragraph">Severity,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-9" href-manipulated="true" aria-label="Reference 21">21</a></sup> criticality,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21-10" href-manipulated="true" aria-label="Reference 21">21</a></sup> and fatality<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="body-ref-r22-5" href-manipulated="true" aria-label="Reference 22">22</a></sup> were defined according to World Health Organization guidelines.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="t3fn6" role="paragraph">The confidence interval could not be estimated because there were zero events among vaccinated participants.</div></div></div></figcaption></figure></div></section><section id="sec-2-4"><h3>Vaccine Effectiveness against Any SARS-CoV-2 Infection According to Age and Variant</h3><div role="paragraph">BNT162b2 effectiveness was assessed according to age (&lt;60 years and ≥60 years) to investigate whether declining effectiveness over time could have been confounded by age. Results for both age groups were largely similar in scale (although effectiveness was slightly lower for those ≥60 years of age, with some differences in the rate at which protection was acquired) and in the pattern of declining effectiveness (Table S4), and results were similar to those for all participants in all age groups (<a href="#t2">Table 2</a>).</div><div role="paragraph">The above measures largely reflect the effectiveness of BNT162b2 against B.1.351,<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r29" id="body-ref-r29-1" href-manipulated="true">2,29</a></sup> which was by far the dominant variant during most of these time periods.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r4 r8 r9 r10" id="body-ref-r10-4" href-manipulated="true">2,4,8–10</a></sup> However, with the steady increase in the incidence of B.1.617.2 during the summer of 2021<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8 r9 r10 r30" id="body-ref-r30-1" href-manipulated="true">8–10,30</a></sup> and the steady decrease in the incidence of B.1.351 during this time,<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8 r9 r10" id="body-ref-r10-6" href-manipulated="true">8-10</a></sup> effectiveness measures 5 or more months after the second dose increasingly reflected effectiveness against B.1.617.2.</div><div role="paragraph">BNT162b2 effectiveness was assessed against B.1.1.7, B.1.351, and B.1.617.2 infections separately to investigate whether declining effectiveness could have been confounded by exposure to different variants over time. Estimated effectiveness against infection with each variant (Table S5) showed a pattern similar to that seen against any SARS-CoV-2 infection (<a href="#t2">Table 2</a>).</div></section><section id="sec-2-5"><h3>Vaccine Effectiveness against Symptomatic and Asymptomatic Infections</h3><div role="paragraph">Estimated BNT162b2 effectiveness against symptomatic infection and asymptomatic infection showed the same pattern of increasing effectiveness after the first dose, with peak effectiveness in the first month after the second dose and a gradual decline in effectiveness in the following months that accelerated after the fourth month for symptomatic infection and after the third month for asymptomatic infection (<a href="#t4">Table 4</a>). However, effectiveness against symptomatic infection was consistently higher than that against asymptomatic infection. The peak effectiveness against symptomatic infection was 81.5% (95% CI, 79.9 to 83.0), whereas that against asymptomatic infection was 73.1% (95% CI, 70.3 to 75.5).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 4</div><nav><a href="#t4" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t4" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t4" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/85333ff3-abda-4e23-8f58-c09aed435afa/assets/images/large/nejmoa2114114_t4.jpg" height="1732" width="2615" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Substudies<a href="#t4fn1" role="doc-noteref">*</a></th><th class="txxx-borders" colspan="5"><span>Effectiveness against Symptomatic Infection<a href="#t4fn2" role="doc-noteref">†</a></span></th><th class="txxr-borders" colspan="5"><span>Effectiveness against Asymptomatic Infection<a href="#t4fn3" role="doc-noteref">‡</a></span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#t4fn4" role="doc-noteref">§</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#t4fn4" role="doc-noteref">§</a></span></th><th class="xxxx-borders">Effectiveness % (95% CI)<a href="#t4fn5" role="doc-noteref">¶</a></th><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#t4fn4" role="doc-noteref">§</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#t4fn4" role="doc-noteref">§</a></span></th><th class="xxxr-borders">Effectiveness % (95% CI)<a href="#t4fn5" role="doc-noteref">¶</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">0–13 Days after first dose</td><td class="xxxx-borders shading">1954</td><td class="xxxx-borders shading">38,814</td><td class="xxxx-borders shading">1864</td><td class="xxxx-borders shading">38,904</td><td class="xxxx-borders shading">−5.5<br>(−12.9 to 1.4)</td><td class="xxxx-borders shading">984</td><td class="xxxx-borders shading">26,988</td><td class="xxxx-borders shading">962</td><td class="xxxx-borders shading">27,010</td><td class="xxxr-borders shading">−2.6<br>(−12.8 to 6.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">≥14 Days after first dose and no second dose</td><td class="xxxx-borders">1074</td><td class="xxxx-borders">39,187</td><td class="xxxx-borders">1922</td><td class="xxxx-borders">38,339</td><td class="xxxx-borders">47.9<br>(43.6 to 51.9)</td><td class="xxxx-borders">516</td><td class="xxxx-borders">26,968</td><td class="xxxx-borders">645</td><td class="xxxx-borders">26,839</td><td class="xxxr-borders">22.2<br>(12.1 to 31.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Month after second dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">1</td><td class="xxxx-borders">867</td><td class="xxxx-borders">40,271</td><td class="xxxx-borders">3756</td><td class="xxxx-borders">37,382</td><td class="xxxx-borders">81.5<br>(79.9 to 83.0)</td><td class="xxxx-borders">781</td><td class="xxxx-borders">27,102</td><td class="xxxx-borders">2202</td><td class="xxxx-borders">25,681</td><td class="xxxr-borders">73.1<br>(70.3 to 75.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">2</td><td class="xxxx-borders shading">650</td><td class="xxxx-borders shading">39,402</td><td class="xxxx-borders shading">1948</td><td class="xxxx-borders shading">38,104</td><td class="xxxx-borders shading">72.5<br>(69.6 to 75.1)</td><td class="xxxx-borders shading">381</td><td class="xxxx-borders shading">27,038</td><td class="xxxx-borders shading">899</td><td class="xxxx-borders shading">26,520</td><td class="xxxr-borders shading">66.9<br>(61.9 to 71.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">3</td><td class="xxxx-borders">372</td><td class="xxxx-borders">39,030</td><td class="xxxx-borders">1040</td><td class="xxxx-borders">38,362</td><td class="xxxx-borders">70.6<br>(66.4 to 74.3)</td><td class="xxxx-borders">239</td><td class="xxxx-borders">26,982</td><td class="xxxx-borders">402</td><td class="xxxx-borders">26,819</td><td class="xxxr-borders">47.7<br>(37.3 to 56.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">4</td><td class="xxxx-borders shading">258</td><td class="xxxx-borders shading">38,829</td><td class="xxxx-borders shading">486</td><td class="xxxx-borders shading">38,601</td><td class="xxxx-borders shading">57.0<br>(48.6 to 64.0)</td><td class="xxxx-borders shading">120</td><td class="xxxx-borders shading">26,956</td><td class="xxxx-borders shading">132</td><td class="xxxx-borders shading">26,944</td><td class="xxxr-borders shading">11.5<br>(−17.1 to 33.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">5</td><td class="xxxx-borders">316</td><td class="xxxx-borders">38,776</td><td class="xxxx-borders">344</td><td class="xxxx-borders">38,748</td><td class="xxxx-borders">12.0<br>(−6.1 to 27.1)</td><td class="xxxx-borders">99</td><td class="xxxx-borders">26,956</td><td class="xxxx-borders">117</td><td class="xxxx-borders">26,938</td><td class="xxxr-borders">24.3<br>(−7.1 to 46.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">6</td><td class="xxxx-borders shading">230</td><td class="xxxx-borders shading">38,800</td><td class="xxxx-borders shading">251</td><td class="xxxx-borders shading">38,779</td><td class="xxxx-borders shading">12.8<br>(−9.1 to 30.3)</td><td class="xxxx-borders shading">125</td><td class="xxxx-borders shading">26,958</td><td class="xxxx-borders shading">124</td><td class="xxxx-borders shading">26,959</td><td class="xxxr-borders shading">−2.1<br>(−52.0 to 31.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">≥7</td><td class="xbxx-borders">75</td><td class="xbxx-borders">38,761</td><td class="xbxx-borders">97</td><td class="xbxx-borders">38,739</td><td class="xbxx-borders">27.8<br>(−1.4 to 48.7)</td><td class="xbxx-borders">29</td><td class="xbxx-borders">26,948</td><td class="xbxx-borders">25</td><td class="xbxx-borders">26,952</td><td class="xbxr-borders">−33.3<br>(−181.8 to 36.9)</td></tr></tbody></table></div><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine against Symptomatic SARS-CoV-2 Infection and Asymptomatic SARS-CoV-2 Infection.</div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t4fn1" role="paragraph">In each analysis for a specific time-since-vaccination stratum, we included only participants vaccinated in this specific time-since-vaccination stratum and those unvaccinated. Only matched pairs of PCR-positive and PCR-negative persons, in which both members of the pair were either unvaccinated or fell within each time-since-vaccination stratum, have been included in the corresponding estimate of vaccine effectiveness. Thus, the number of case participants (and controls) varied across time-since-vaccination analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t4fn2" role="paragraph">A symptomatic infection was defined as a PCR-positive test conducted because of clinical suspicion due to the presence of symptoms compatible with a respiratory tract infection.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t4fn3" role="paragraph">An asymptomatic infection was defined as a PCR-positive test conducted with no reported presence of symptoms compatible with a respiratory tract infection — that is, the PCR testing was done as part of a survey or a random testing campaign.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="t4fn4" role="paragraph">Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for PCR testing, and calendar week of PCR test.</div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="t4fn5" role="paragraph">Vaccine effectiveness was estimated with the use of the test-negative, case–control study design.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-7" href-manipulated="true">11,12</a></sup></div></div></div></figcaption></figure></div></section><section id="sec-2-6"><h3>Vaccine Effectiveness against Covid-19–Related Hospitalization and Death</h3><div role="paragraph">Estimated BNT162b2 effectiveness against any severe, critical, or fatal disease due to any SARS-CoV-2 infection was negligible for the first 2 weeks after the first dose. It increased rapidly to 66.1% (95% CI, 56.8 to 73.5) in the third week after the first dose and reached 96% or higher in the first 2 months after the second dose (<a href="#t2">Table 2</a> and <a href="#f2">Figure 2B</a>). Unlike effectiveness against infection, effectiveness against hospitalization and death did not decline over time, except possibly in the seventh month after the second dose when there was a hint of a decline, but the case numbers were small. The sensitivity analysis that adjusted for previous infection and health care worker status confirmed the main analysis results (<a href="#t3">Table 3</a>). Effectiveness according to age group (Table S4) showed similar results.</div><div role="paragraph">Effectiveness was also estimated against severe disease, critical disease, and fatal disease individually (Table S6), as opposed to against a composite outcome of any severe, critical, or fatal disease (<a href="#t2">Table 2</a>). Estimated effectiveness against each of these individual disease outcomes was similar to that against the composite disease outcome, with no evident decline in effectiveness for 6 months after the second dose.</div></section><section id="sec-2-7"><h3>Additional Analyses</h3><div role="paragraph">Additional sensitivity analyses were conducted to investigate the effects of potential bias in these real-world effectiveness estimates (Section 5 in the <a href="#ap1">Supplementary Appendix</a>). All analyses generated consistent results, with the same pattern of declining effectiveness in the months after the second dose (Tables S7 through S10) as was observed in the main analysis (<a href="#t2">Table 2</a>).</div><div role="paragraph">For additional validation of study findings, effectiveness was estimated with the use of a different method from that of the matched test-negative, case–control study design. Estimates were derived with the use of multivariable logistic-regression analysis of associations with a PCR-positive test during the study (Table S11). This analysis also generated results similar to those of the main analysis (<a href="#t2">Table 2</a>).</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">BNT162b2-induced protection against infection builds rapidly after the first dose, peaks in the first month after the second dose, and then gradually wanes in subsequent months. The waning appears to accelerate after the fourth month, to reach a low level of approximately 20% in subsequent months. Although the protection against asymptomatic infection diminished more quickly than that against symptomatic infection, as would be expected in a vaccine that prevents symptoms given infection,<sup><a href="#core-r31" role="doc-biblioref" data-xml-rid="r31 r32" id="body-ref-r32" href-manipulated="true">31,32</a></sup> no evidence was found for an appreciable waning of protection against hospitalization and death, which remained robust — generally at 90% or higher — for 6 months after the second dose. Implications of these findings on infection transmission remain to be clarified, but vaccine breakthrough infections were found recently, in this same population, to be less infectious than primary infections in unvaccinated persons.<sup><a href="#core-r33" role="doc-biblioref" data-xml-rid="r33" id="body-ref-r33" href-manipulated="true" aria-label="Reference 33">33</a></sup></div><div role="paragraph">Because the immunization campaign prioritized vaccination of persons with severe or multiple chronic conditions and prioritized vaccination according to age group, this pattern of waning of protection could theoretically be confounded by effects of age and coexisting conditions. However, this possibility was not supported by our results, because a similar pattern of waning of protection was observed for all ages. Old age may (partially) serve as a proxy for coexisting conditions, and the number of persons with severe or multiple chronic conditions is small among the young, working-age population of Qatar.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r28" id="body-ref-r28-2" href-manipulated="true">17,28</a></sup> The national list of vaccine prioritization included only 19,800 persons of all age groups with serious coexisting conditions to be prioritized in the first phase of vaccine rollout.</div><div role="paragraph">Infection incidence was driven by different variants over time; thus, it is possible that waning of protection could be confounded by exposure to different variants at different time points. However, this seems unlikely. By far the dominant variant during the study was B.1.351,<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r4 r8 r9 r10" id="body-ref-r10-7" href-manipulated="true">2,4,8–10</a></sup> and a similar pattern of waning of protection was observed for B.1.1.7, B.1.351, and B.1.617.2.</div><div role="paragraph">Vaccinated persons presumably have a higher rate of social contact than unvaccinated persons and may also have lower adherence to safety measures.<sup><a href="#core-r34" role="doc-biblioref" data-xml-rid="r34 r35 r36" id="body-ref-r36-1" href-manipulated="true">34-36</a></sup> This behavior could reduce real-world effectiveness of the vaccine as compared with its biologic effectiveness, possibly explaining the waning of protection. Public health restrictions have been easing gradually in Qatar but differently for vaccinated and unvaccinated persons. Many social, work, and travel activities now require evidence of vaccination (a “health pass”) that is administered through a mandatory mobile app (the Ehteraz app). Risk compensation may be even higher with increasing time since receipt of the second dose — that is, there could be a progressive normalization of behavior.<sup><a href="#core-r35" role="doc-biblioref" data-xml-rid="r35 r36 r37" id="body-ref-r37" href-manipulated="true">35-37</a></sup> However, risk compensation is perhaps more likely to affect the overall level of estimated effectiveness than the observed rapid waning of protection over time, unless such risk compensation increases rapidly with time after the second dose.</div><div role="paragraph">PCR testing in Qatar is done on a mass scale, with approximately 5% of the population being tested every week.<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5" id="body-ref-r5-2" href-manipulated="true" aria-label="Reference 5">5</a></sup> Approximately 75% of those who receive a diagnosis of SARS-CoV-2 infection at present do so not because of the appearance of symptoms but because of routine testing. It is possible that many asymptomatic infections were diagnosed among vaccinated participants that otherwise would have been missed. The higher ascertainment of infection may have lowered the effectiveness estimates. This idea is supported by the observed lower effectiveness against asymptomatic infection.</div><div role="paragraph">Emerging evidence supports the findings of this study. An increasing number of studies suggest substantial waning of BNT162b2 effectiveness.<sup><a href="#core-r38" role="doc-biblioref" data-xml-rid="r38 r39 r40 r41 r42" id="body-ref-r42-1" href-manipulated="true">38-42</a></sup> The findings are also supported by recent reports from Israel and the United States that indicate declining BNT162b2 effectiveness against infection with elapsed time and according to calendar month.<sup><a href="#core-r42" role="doc-biblioref" data-xml-rid="r42 r43 r44 r45 r46" id="body-ref-r46-1" href-manipulated="true">42-46</a></sup> Our findings, along with the greater immunogenicity of a schedule with a longer dose interval,<sup><a href="#core-r47" role="doc-biblioref" data-xml-rid="r47" id="body-ref-r47" href-manipulated="true" aria-label="Reference 47">47</a></sup> may also explain the observed low effectiveness against B.1.617.2 in countries where the second dose was implemented 3 weeks after the first dose, such as in Israel,<sup><a href="#core-r43" role="doc-biblioref" data-xml-rid="r43" id="body-ref-r43-2" href-manipulated="true" aria-label="Reference 43">43</a></sup> Qatar,<sup><a href="#core-r30" role="doc-biblioref" data-xml-rid="r30" id="body-ref-r30-2" href-manipulated="true" aria-label="Reference 30">30</a></sup> and the United States,<sup><a href="#core-r46" role="doc-biblioref" data-xml-rid="r46" id="body-ref-r46-2" href-manipulated="true" aria-label="Reference 46">46</a></sup> where B.1.617.2 has been dominant at a time when a nonnegligible proportion of the population had their second dose in January or February of 2021. However, higher effectiveness against B.1.617.2 has been observed in countries where a delayed interval schedule has been implemented, such as in Canada<sup><a href="#core-r15" role="doc-biblioref" data-xml-rid="r15" id="body-ref-r15-2" href-manipulated="true" aria-label="Reference 15">15</a></sup> and the United Kingdom,<sup><a href="#core-r13" role="doc-biblioref" data-xml-rid="r13 r14" id="body-ref-r14-2" href-manipulated="true">13,14</a></sup> where B.1.617.2 became dominant at a time when a negligible proportion of the population had their second dose in January or February of 2021.</div><div role="paragraph">This study has limitations. Individual-level data on coexisting conditions were not available; therefore, they could not be explicitly factored into our analysis. However, adjusting for age may have served, in part, as a proxy. With the young population of Qatar,<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r28" id="body-ref-r28-3" href-manipulated="true">17,28</a></sup> only a small proportion of the study population may have had serious coexisting conditions. Only 9% of the population are 50 years of age or older,<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r28" id="body-ref-r28-4" href-manipulated="true">17,28</a></sup> and 60% are young, expatriate craft and manual workers involved in mega-development projects.<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18 r19 r48" id="body-ref-r48" href-manipulated="true">18,19,48</a></sup> Our findings may not be generalizable to other countries where elderly persons constitute a sizable proportion of the total population.</div><div role="paragraph">Effectiveness was assessed with the use of an observational, test-negative, case–control study design,<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="body-ref-r12-8" href-manipulated="true">11,12</a></sup> rather than a randomized, clinical trial design, in which cohorts of vaccinated and unvaccinated persons were followed. We were unable to use a cohort study design owing to depletion of the unvaccinated cohorts by the high vaccine coverage. However, the cohort study design that was applied earlier to the same population of Qatar yielded findings similar to those reported for the test-negative, case–control design,<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r4" id="body-ref-r4-6" href-manipulated="true">2,4</a></sup> which supports the validity of this standard approach in assessing vaccine effectiveness for respiratory tract infections.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r4 r11 r12 r13 r14 r15" id="body-ref-r15-3" href-manipulated="true">2,4,11–15</a></sup> The results of this study are also consistent with our previous estimates of vaccine effectiveness immediately after the first and second doses.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2 r29" id="body-ref-r29-2" href-manipulated="true">2,29</a></sup> We note that the earlier estimates involved (mostly) symptomatic infections with low PCR cycle threshold values, whereas the present study estimates involve (mostly) asymptomatic infections of both high and low PCR cycle threshold values.</div><div role="paragraph">Nonetheless, one cannot rule out the possibility that in real-world data, bias could arise in unexpected ways or from unknown sources, such as subtle differences in test-seeking behavior or changes in the pattern of testing with the introduction of other testing approaches, such as rapid antigen testing. For example, inclusion of PCR testing before travel or at port of entry was found to introduce a negative bias — that is, lowering the effectiveness estimates (Table S10) — perhaps because of different test-seeking behaviors of those vaccinated as compared with those unvaccinated, as a consequence of the travel privileges granted only to vaccinated persons.<sup><a href="#core-r49" role="doc-biblioref" data-xml-rid="r49" id="body-ref-r49" href-manipulated="true" aria-label="Reference 49">49</a></sup></div><div role="paragraph">Vaccine effectiveness for participants at 0 to 13 days after the first dose was just below zero, possibly suggesting a negative bias. However, this has also been observed elsewhere for both Covid-19 vaccines<sup><a href="#core-r50" role="doc-biblioref" data-xml-rid="r50 r51 r52" id="body-ref-r52" href-manipulated="true">50-52</a></sup> and other vaccines.<sup><a href="#core-r53" role="doc-biblioref" data-xml-rid="r53" id="body-ref-r53-1" href-manipulated="true" aria-label="Reference 53">53</a></sup> This effect may reflect differences in social behavior at or after vaccination or an immunologic effect.<sup><a href="#core-r53" role="doc-biblioref" data-xml-rid="r53" id="body-ref-r53-2" href-manipulated="true" aria-label="Reference 53">53</a></sup></div><div role="paragraph">Notwithstanding these limitations, consistent findings of this study were reached that indicated a large effect size for the waning of vaccine protection over time, regardless of the reason for PCR testing and whether there were symptoms. Moreover, with the mass scale of PCR testing in Qatar,<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5" id="body-ref-r5-3" href-manipulated="true" aria-label="Reference 5">5</a></sup> the likelihood of bias is perhaps minimized. Indeed, the different sensitivity and additional analyses that were conducted to investigate effects of potential bias, such as by modifying the inclusion and exclusion criteria, all yielded findings that indicated a rapid waning of vaccine protection.</div><div role="paragraph">In this study, we found that BNT162b2-induced protection against infection peaked in the first month after the second dose and then gradually waned month by month, before reaching low levels 5 to 7 months after the second dose. Meanwhile, BNT162b2-induced protection against hospitalization and death persisted with hardly any waning for 6 months after the second dose. These findings suggest that a large proportion of the vaccinated population could lose its protection against infection in the coming months, perhaps increasing the potential for new epidemic waves.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="published/updated" role="paragraph">This article was published on October 6, 2021, at NEJM.org.</div><div role="paragraph">Supported by the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at <span class="named-content" data-type="funder">Weill Cornell Medicine–Qatar</span> ; the Ministry of Public Health; and <span class="named-content" data-type="funder">Hamad Medical Corporation</span>. The Qatar Genome Program provided the reagents for the viral genome sequencing.</div><div role="paragraph"><a href="#ap2">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div><div role="paragraph">We thank the staffs of Hamad Medical Corporation, the Ministry of Public Health, the Primary Health Care Corporation, Qatar Biobank, Sidra Medicine, and Weill Cornell Medicine–Qatar for the diligent efforts and contributions that made this study possible.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2114114_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2114114/suppl_file/nejmoa2114114_appendix.pdf" download="nejmoa2114114_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2114114_appendix.pdf" data-doi="10.1056/NEJMoa2114114">Download</a></li><li>806.65 KB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2114114_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2114114/suppl_file/nejmoa2114114_disclosures.pdf" download="nejmoa2114114_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2114114_disclosures.pdf" data-doi="10.1056/NEJMoa2114114">Download</a></li><li>456.48 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r1" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r1" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r1-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] December 21, 2020, first using the BNT162b2 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and Drug Administration–approved protocol, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. <em>N Engl J Med</em> 2021;385:187-189.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r2" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_3_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMc2104974&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951357/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+BNT162b2+Covid-19+vaccine+against+the+B.1.1.7+and+B.1.351+variants.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=187-189&amp;doi=10.1056%2FNEJMc2104974&amp;pmid=33951357" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r2" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r2-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] messenger RNA (mRNA) vaccine </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] effectiveness of BNT162b2 against B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] variant during the study was B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r4-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] for the test-negative, case–control design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>h [...] for respiratory tract infections. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>i [...] after the first and second doses. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r3-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and 3 months later adding the mRNA-1273 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and Drug Administration–approved protocol, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Chemaitelly H, Yassine HM, Benslimane FM, et al. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. <em>Nat Med</em> 2021;27:1614-1621.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r4" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-021-01446-y" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34244681/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000671528900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=mRNA-1273+COVID-19+vaccine+effectiveness+against+the+B.1.1.7+and+B.1.351+variants+and+severe+COVID-19+disease+in+Qatar.&amp;publication_year=2021&amp;journal=Nat+Med&amp;pages=1614-1621&amp;doi=10.1038%2Fs41591-021-01446-y&amp;pmid=34244681" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r4" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r4-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] (Moderna) vaccine. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] variant during the study was B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r4-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] for the test-negative, case–control design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Qatar Ministry of Public Health. National Covid-19 vaccination program data, 2021 (<a href="https://covid19.moph.gov.qa/EN/Pages/Vaccination-Program-Data.aspx">https://covid19.moph.gov.qa/EN/Pages/Vaccination-Program-Data.aspx</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r5" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=National+Covid-19+vaccination+program+data&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r5" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] that at least 80% had received both doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r5-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of the population being tested every week. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r5-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] the mass scale of PCR testing in Qatar, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Coronavirus (COVID-19) vaccinations. <em>Our World in Data</em>, 2021 (<a href="https://ourworldindata.org/covid-vaccinations">https://ourworldindata.org/covid-vaccinations</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Coronavirus+%28COVID-19%29+vaccinations&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">World Health Organization. Tracking SARS-CoV-2 variants. 2021 (<a href="https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/">https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Tracking+SARS-CoV-2+variants&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r7-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] were dominated by the B.1.1.7 (or alpha) </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r7-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and B.1.351 (or beta) </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r7-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] transmission of the B.1.617.2 (or delta) </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Qatar viral genome sequencing data: data on randomly collected samples. <em>GISAID</em>, 2021 (<a href="https://www.gisaid.org/phylodynamics/global/nextstrain/">https://www.gisaid.org/phylodynamics/global/nextstrain/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Qatar+viral+genome+sequencing+data%3A+data+on+randomly+collected+samples.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] B.1.617.2 had become the dominant variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] of random positive clinical samples </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] the incidence of B.1.351 during this time, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] variant during the study was B.1.351, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Benslimane FM, Al Khatib HA, Al-Jamal O, et al. One year of SARS-CoV-2: genomic characterization of COVID-19 outbreak in Qatar. May 20, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.05.19.21257433v2">https://www.medrxiv.org/content/10.1101/2021.05.19.21257433v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=One+year+of+SARS-CoV-2%3A+genomic+characterization+of+COVID-19+outbreak+in+Qatar.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] B.1.617.2 had become the dominant variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] the incidence of B.1.351 during this time, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] variant during the study was B.1.351, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Hasan MR, Kalikiri MKR, Mirza F, et al. Real-time SARS-CoV-2 genotyping by high-throughput multiplex PCR reveals the epidemiology of the variants of concern in Qatar. <em>Int J Infect Dis</em> 2021 September 12 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.ijid.2021.09.006" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3425398/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000706527200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Real-time+SARS-CoV-2+genotyping+by+high-throughput+multiplex+PCR+reveals+the+epidemiology+of+the+variants+of+concern+in+Qatar.&amp;publication_year=2021&amp;journal=Int+J+Infect+Dis&amp;doi=10.1016%2Fj.ijid.2021.09.006&amp;pmid=3425398" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] B.1.617.2 had become the dominant variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] of random positive clinical samples </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] the incidence of B.1.351 during this time, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] variant during the study was B.1.351, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. <em>Vaccine</em> 2013;31:2165-2168.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r11" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2013.02.053" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23499601/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000318329400010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+test-negative+design+for+estimating+influenza+vaccine+effectiveness.&amp;publication_year=2013&amp;journal=Vaccine&amp;pages=2165-2168&amp;doi=10.1016%2Fj.vaccine.2013.02.053&amp;pmid=23499601" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r11" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] vaccine effectiveness against influenza </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] vaccinated and unvaccinated persons. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] result from variation in epidemic phase, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] rollout of vaccination during the study, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] by applying the following equation </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r11-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r11-8"><i aria-hidden="true" class="icon-return"></i><span>h [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t4" role="menuitem" data-target="#fv-body-ref-r11-9"><i aria-hidden="true" class="icon-return"></i><span>i [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>j [...] test-negative, case–control study design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>k [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Verani JR, Baqui AH, Broome CV, et al. Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls. <em>Vaccine</em> 2017;35:3295-3302.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2017.04.037" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28442231/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000403134200003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Case-control+vaccine+effectiveness+studies%3A+preparation%2C+design%2C+and+enrollment+of+cases+and+controls.&amp;publication_year=2017&amp;journal=Vaccine&amp;pages=3295-3302&amp;doi=10.1016%2Fj.vaccine.2017.04.037&amp;pmid=28442231" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] vaccine effectiveness against influenza </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] vaccinated and unvaccinated persons. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] by applying the following equation </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r12-5"><i aria-hidden="true" class="icon-return"></i><span>e [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r12-6"><i aria-hidden="true" class="icon-return"></i><span>f [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t4" role="menuitem" data-target="#fv-body-ref-r12-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>h [...] test-negative, case–control study design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>i [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. <em>N Engl J Med</em> 2021;385:585-594.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r13" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_14_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMoa2108891&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34289274/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000675554200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Covid-19+vaccines+against+the+B.1.617.2+%28Delta%29+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=585-594&amp;doi=10.1056%2FNEJMoa2108891&amp;pmid=34289274" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r13" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and the United Kingdom, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Sheikh A, McMenamin J, Taylor B, Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. <em>Lancet</em> 2021;397:2461-2462.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r14" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)01358-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34139198/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667322400021" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+Delta+VOC+in+Scotland%3A+demographics%2C+risk+of+hospital+admission%2C+and+vaccine+effectiveness.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=2461-2462&amp;doi=10.1016%2FS0140-6736%2821%2901358-1&amp;pmid=34139198" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r14" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and the United Kingdom, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Nasreen S, He S, Chung H, et al. Effectiveness of COVID-19 vaccines against variants of concern, Canada. July 3, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v1">https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r15" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+variants+of+concern%2C+Canada.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r15" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] has been implemented, such as in Canada </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Dean NE, Hogan JW, Schnitzer ME. Covid-19 vaccine effectiveness and the test-negative design. <em>N Engl J Med</em> 2021;385:1431-1433.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_17_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMe2113151&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34496195/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000693740100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Covid-19+vaccine+effectiveness+and+the+test-negative+design.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1431-1433&amp;doi=10.1056%2FNEJMe2113151&amp;pmid=34496195" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. <em>Sci Rep</em> 2021;11:6233-6233.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r17" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-021-85428-7" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33737535/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667581800033" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Characterizing+the+Qatar+advanced-phase+SARS-CoV-2+epidemic.&amp;publication_year=2021&amp;journal=Sci+Rep&amp;pages=6233-6233&amp;doi=10.1038%2Fs41598-021-85428-7&amp;pmid=33737535" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r17" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] characteristics of the population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] the young, working-age population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] proxy. With the young population of Qatar, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] population are 50 years of age or older, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">Al-Thani MH, Farag E, Bertollini R, et al. SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar. <em>Open Forum Infect Dis</em> 2021;8(8):ofab221-ofab221.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r18" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/ofid/ofab221" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34458388/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000728385400013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+infection+is+at+herd+immunity+in+the+majority+segment+of+the+population+of+Qatar.&amp;publication_year=2021&amp;journal=Open+Forum+Infect+Dis&amp;pages=ofab221-ofab221&amp;doi=10.1093%2Fofid%2Fofab221&amp;pmid=34458388" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r18" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r48" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] involved in mega-development projects. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Jeremijenko A, Chemaitelly H, Ayoub HH, et al. Herd immunity against severe acute respiratory syndrome coronavirus 2 infection in 10 communities, Qatar. <em>Emerg Infect Dis</em> 2021;27:1343-1352.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.3201/eid2705.204365" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33900174/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000650121700012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Herd+immunity+against+severe+acute+respiratory+syndrome+coronavirus+2+infection+in+10+communities%2C+Qatar.&amp;publication_year=2021&amp;journal=Emerg+Infect+Dis&amp;pages=1343-1352&amp;doi=10.3201%2Feid2705.204365&amp;pmid=33900174" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r48" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] involved in mega-development projects. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">Coyle PV, Chemaitelly H, Ben Hadj Kacem MA, et al. SARS-CoV-2 seroprevalence in the urban population of Qatar: an analysis of antibody testing on a sample of 112,941 individuals. <em>iScience</em> 2021;24:102646-102646.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r20" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.isci.2021.102646" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34056566/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667301700075" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+seroprevalence+in+the+urban+population+of+Qatar%3A+an+analysis+of+antibody+testing+on+a+sample+of+112%2C941+individuals.&amp;publication_year=2021&amp;journal=iScience&amp;pages=102646-102646&amp;doi=10.1016%2Fj.isci.2021.102646&amp;pmid=34056566" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r20" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">COVID-19 clinical management: living guidance. Geneva: World Health Organization, January 25, 2021 (<a href="https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1">https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r21" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+clinical+management%3A+living+guidance&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r21" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r21-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] symptoms), as well as against any severe, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] critical, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] severity (acute-care hospitalizations), </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] (intensive care unit hospitalizations), </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] Covid-19 cases (acute-care hospitalizations </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] Covid-19 cases (ICU hospitalizations </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r21-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] Severity, </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r21-8"><i aria-hidden="true" class="icon-return"></i><span>h [...] criticality, </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r21-9"><i aria-hidden="true" class="icon-return"></i><span>i [...] Severity, </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r21-10"><i aria-hidden="true" class="icon-return"></i><span>j [...] criticality, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="r22" class="citations"><div class="citation"><div class="citation-content">International guidelines for certification and classification (coding) of COVID-19 as cause of death. Geneva: World Health Organization, April 20, 2020 (<a href="https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19-20200420-EN.pdf?ua=1">https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19-20200420-EN.pdf?ua=1</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r22" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=International+guidelines+for+certification+and+classification+%28coding%29+of+COVID-19+as+cause+of+death&amp;publication_year=2020" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r22" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] or fatal </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and fatality </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] Covid-19 cases (Covid-19–related deaths </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r22-4"><i aria-hidden="true" class="icon-return"></i><span>d [...] and fatality </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r22-5"><i aria-hidden="true" class="icon-return"></i><span>e [...] and fatality </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="r23" class="citations"><div class="citation"><div class="citation-content">Vogels C, Fauver J, Grubaugh N. Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern V.3. February 9, 2021 (<a href="https://www.protocols.io/view/multiplexed-rt-qpcr-to-screen-for-sars-cov-2-b-1-1-br9vm966">https://www.protocols.io/view/multiplexed-rt-qpcr-to-screen-for-sars-cov-2-b-1-1-br9vm966</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r23"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Multiplexed+RT-qPCR+to+screen+for+SARS-COV-2+B.1.1.7%2C+B.1.351%2C+and+P.1+variants+of+concern+V.3.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="r24" class="citations"><div class="citation"><div class="citation-content">Jacoby P, Kelly H. Is it necessary to adjust for calendar time in a test negative design? Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8. <em>Vaccine</em> 2014;32:2942-2942.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r24" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2013.08.048" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24016812/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000336713000003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Is+it+necessary+to+adjust+for+calendar+time+in+a+test+negative+design%3F+Responding+to%3A+Jackson+ML%2C+Nelson+JC.+The+test+negative+design+for+estimating+influenza+vaccine+effectiveness.+Vaccine+2013%3B31%28April+%2817%29%29%3A2165-8.&amp;publication_year=2014&amp;journal=Vaccine&amp;pages=2942-2942&amp;doi=10.1016%2Fj.vaccine.2013.08.048&amp;pmid=24016812" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r24" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r24-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] result from variation in epidemic phase, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] rollout of vaccination during the study, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="r25" class="citations"><div class="citation"><div class="citation-content">Pearce N. Analysis of matched case-control studies. <em>BMJ</em> 2016;352:i969-i969.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.i969" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26916049/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000371116400004" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Analysis+of+matched+case-control+studies.&amp;publication_year=2016&amp;journal=BMJ&amp;pages=i969-i969&amp;doi=10.1136%2Fbmj.i969&amp;pmid=26916049" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="r26" class="citations"><div class="citation"><div class="citation-content">Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams &amp; Wilkins, 2008.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Modern+epidemiology.+3rd+ed.&amp;publication_year=2008" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">27.</div><div id="r27" class="citations"><div class="citation"><div class="citation-content">Stata statistical software: release 17. College Station, TX: StataCorp. 2021 (<a href="https://www.stata.com/">https://www.stata.com/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r27"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Stata+statistical+software%3A+release+17&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">28.</div><div id="r28" class="citations"><div class="citation"><div class="citation-content">Planning and Statistics Authority. Qatar monthly statistics. <em>State of Qatar</em> (<a href="https://www.psa.gov.qa/en/pages/default.aspx">https://www.psa.gov.qa/en/pages/default.aspx</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r28" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Qatar+monthly+statistics" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r28" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r28-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] characteristics of the population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] the young, working-age population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] proxy. With the young population of Qatar, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] population are 50 years of age or older, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">29.</div><div id="r29" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Yassine HM, et al. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. <em>J Travel Med</em> 2021 May 28 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r29" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jtm/taab083" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34050372/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000711240500008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Pfizer-BioNTech+mRNA+BNT162b2+Covid-19+vaccine+protection+against+variants+of+concern+after+one+versus+two+doses.&amp;publication_year=2021&amp;journal=J+Travel+Med&amp;doi=10.1093%2Fjtm%2Ftaab083&amp;pmid=34050372" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r29" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r29-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] effectiveness of BNT162b2 against B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after the first and second doses. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">30.</div><div id="r30" class="citations"><div class="citation"><div class="citation-content">Tang P, Hasan MR, Chemaitelly H, et al. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar. August 11, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.11.21261885v1">https://www.medrxiv.org/content/10.1101/2021.08.11.21261885v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r30" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BNT162b2+and+mRNA-1273+COVID-19+vaccine+effectiveness+against+the+Delta+%28B.1.617.2%29+variant+in+Qatar.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r30" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 43 Qatar, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">31.</div><div id="r31" class="citations"><div class="citation"><div class="citation-content">Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. <em>Lancet Infect Dis</em> 2021;21(2):e26-e35.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r32"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S1473-3099(20)30773-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33125914/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000614630600003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=What+defines+an+efficacious+COVID-19+vaccine%3F+A+review+of+the+challenges+assessing+the+clinical+efficacy+of+vaccines+against+SARS-CoV-2.&amp;publication_year=2021&amp;journal=Lancet+Infect+Dis&amp;pages=e26-e35&amp;doi=10.1016%2FS1473-3099%2820%2930773-8&amp;pmid=33125914" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">32.</div><div id="r32" class="citations"><div class="citation"><div class="citation-content">Williams LR, Ferguson NM, Donnelly CA, Grassly NC. Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates. July 31, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.30.21260912v1">https://www.medrxiv.org/content/10.1101/2021.07.30.21260912v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r32"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Measuring+vaccine+efficacy+against+infection+and+disease+in+clinical+trials%3A+sources+and+magnitude+of+bias+in+COVID-19+vaccine+efficacy+estimates.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">33.</div><div id="r33" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Effect of vaccination and of prior infection on infectiousness of vaccine breakthrough infections and reinfections. July 30, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.28.21261086v1">https://www.medrxiv.org/content/10.1101/2021.07.28.21261086v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effect+of+vaccination+and+of+prior+infection+on+infectiousness+of+vaccine+breakthrough+infections+and+reinfections.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">34.</div><div id="r34" class="citations"><div class="citation"><div class="citation-content">Makhoul M, Ayoub HH, Chemaitelly H, et al. Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses. <em>Vaccines (Basel)</em> 2020;8:668-668.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r36-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/vaccines8040668" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33182403/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000601676700001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Epidemiological+impact+of+SARS-CoV-2+vaccination%3A+mathematical+modeling+analyses.&amp;publication_year=2020&amp;journal=Vaccines+%28Basel%29&amp;pages=668-668&amp;doi=10.3390%2Fvaccines8040668&amp;pmid=33182403" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">35.</div><div id="r35" class="citations"><div class="citation"><div class="citation-content">Usherwood T, LaJoie Z, Srivastava V. A model and predictions for COVID-19 considering population behavior and vaccination. <em>Sci Rep</em> 2021;11:12051-12051.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r35" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-021-91514-7" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34103618/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000663012100002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+model+and+predictions+for+COVID-19+considering+population+behavior+and+vaccination.&amp;publication_year=2021&amp;journal=Sci+Rep&amp;pages=12051-12051&amp;doi=10.1038%2Fs41598-021-91514-7&amp;pmid=34103618" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r35" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r36-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] have lower adherence to safety measures. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r37" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] be a progressive normalization of behavior. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">36.</div><div id="r36" class="citations"><div class="citation"><div class="citation-content">Andersson O, Campos-Mercade P, Meier AN, Wengström E. Anticipation of COVID-19 vaccines reduces social distancing. January 15, 2021 (<a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765329">https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765329</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r36" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Anticipation+of+COVID-19+vaccines+reduces+social+distancing.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r36" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r36-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] have lower adherence to safety measures. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r37" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] be a progressive normalization of behavior. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">37.</div><div id="r37" class="citations"><div class="citation"><div class="citation-content">Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? <em>BMJ</em> 2006;332:605-607.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r37"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.332.7541.605" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16528088/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000236314400023" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Risk+compensation%3A+the+Achilles%E2%80%99+heel+of+innovations+in+HIV+prevention%3F&amp;publication_year=2006&amp;journal=BMJ&amp;pages=605-607&amp;doi=10.1136%2Fbmj.332.7541.605&amp;pmid=16528088" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">38.</div><div id="r38" class="citations"><div class="citation"><div class="citation-content">Israel A, Merzon E, Schäffer AA, et al. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. August 5, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1">https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Elapsed+time+since+BNT162b2+vaccine+and+risk+of+SARS-CoV-2+infection+in+a+large+cohort.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">39.</div><div id="r39" class="citations"><div class="citation"><div class="citation-content">Thomas SJ, Moreira ED, Kitchin N, et al. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. July 28, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1">https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Six+month+safety+and+efficacy+of+the+BNT162b2+mRNA+COVID-19+vaccine.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">40.</div><div id="r40" class="citations"><div class="citation"><div class="citation-content">Mizrahi B, Lotan R, Kalkstein N, et al. Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine, preliminary study. July 31, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1">https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Correlation+of+SARS-CoV-2+breakthrough+infections+to+time-from-vaccine%2C+preliminary+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">41.</div><div id="r41" class="citations"><div class="citation"><div class="citation-content">Pouwels KB, Pritchard E, Matthews PC, et al. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. August 24, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1">https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+of+Delta+on+viral+burden+and+vaccine+effectiveness+against+new+SARS-CoV-2+infections+in+the+UK.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">42.</div><div id="r42" class="citations"><div class="citation"><div class="citation-content">Keehner J, Horton LE, Binkin NJ, et al. Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. <em>N Engl J Med</em> 2021;385:1330-1332.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r42" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_43_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMc2112981&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34469645/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000691735900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Resurgence+of+SARS-CoV-2+infection+in+a+highly+vaccinated+health+system+workforce.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1330-1332&amp;doi=10.1056%2FNEJMc2112981&amp;pmid=34469645" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r42" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r42-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] waning of BNT162b2 effectiveness. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r46-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] time and according to calendar month. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">43.</div><div id="r43" class="citations"><div class="citation"><div class="citation-content">Israeli Ministry of Health. COVID-19 vaccine effectiveness against the Delta variant: Israel’s Ministry of Health report. 2021 (<a href="https://www.gov.il/BlobFolder/reports/vaccine-efficacy-safety-follow-up-committee/he/files_publications_corona_two-dose-vaccination-data.pdf">https://www.gov.il/BlobFolder/reports/vaccine-efficacy-safety-follow-up-committee/he/files_publications_corona_two-dose-vaccination-data.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r43" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+effectiveness+against+the+Delta+variant%3A+Israel%E2%80%99s+Ministry+of+Health+report&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r43" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r46-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] time and according to calendar month. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r43-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after the first dose, such as in Israel, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">44.</div><div id="r44" class="citations"><div class="citation"><div class="citation-content">Nanduri S, Pilishvili T, Derado G, et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines in preventing SARS-CoV-2 infection among nursing home residents before and during widespread circulation of the SARS-CoV-2 B.1.617.2 (Delta) variant — National Healthcare Safety Network, March 1–August 1, 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1163-1166.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r46-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7034e3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34437519/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000691315200006" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Pfizer-BioNTech+and+Moderna+vaccines+in+preventing+SARS-CoV-2+infection+among+nursing+home+residents+before+and+during+widespread+circulation+of+the+SARS-CoV-2+B.1.617.2+%28Delta%29+variant+%E2%80%94+National+Healthcare+Safety+Network%2C+March+1%E2%80%93August+1%2C+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1163-1166&amp;doi=10.15585%2Fmmwr.mm7034e3&amp;pmid=34437519" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">45.</div><div id="r45" class="citations"><div class="citation"><div class="citation-content">Rosenberg ES, Holtgrave DR, Dorabawila V, et al. New COVID-19 cases and hospitalizations among adults, by vaccination status — New York, May 3–July 25, 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1150-1155.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r46-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7034e1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34437517/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=New+COVID-19+cases+and+hospitalizations+among+adults%2C+by+vaccination+status+%E2%80%94+New+York%2C+May+3%E2%80%93July+25%2C+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1150-1155&amp;doi=10.15585%2Fmmwr.mm7034e1&amp;pmid=34437517" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">46.</div><div id="r46" class="citations"><div class="citation"><div class="citation-content">Puranik A, Lenehan PJ, Silvert E, et al. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. August 21, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v3">https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v3</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r46" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Comparison+of+two+highly-effective+mRNA+vaccines+for+COVID-19+during+periods+of+Alpha+and+Delta+variant+prevalence.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r46" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r46-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] time and according to calendar month. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r46-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and the United States, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">47.</div><div id="r47" class="citations"><div class="citation"><div class="citation-content">Flaxman A, Marchevsky NG, Jenkin D, et al. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). <em>Lancet</em> 2021;398:981-990.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r47"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)01699-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34480858/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000695130500024" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reactogenicity+and+immunogenicity+after+a+late+second+dose+or+a+third+dose+of+ChAdOx1+nCoV-19+in+the+UK%3A+a+substudy+of+two+randomised+controlled+trials+%28COV001+and+COV002%29.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=981-990&amp;doi=10.1016%2FS0140-6736%2821%2901699-8&amp;pmid=34480858" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">48.</div><div id="r48" class="citations"><div class="citation"><div class="citation-content">Planning and Statistics Authority. Labor force sample survey. <em>State of Qatar</em>, 2017 (<a href="https://www.psa.gov.qa/en/statistics/Statistical%20Releases/Social/LaborForce/2017/statistical_analysis_labor_force_2017_En.pdf">https://www.psa.gov.qa/en/statistics/Statistical%20Releases/Social/LaborForce/2017/statistical_analysis_labor_force_2017_En.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r48"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Labor+force+sample+survey.&amp;publication_year=2017" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">49.</div><div id="r49" class="citations"><div class="citation"><div class="citation-content">Bertollini R, Chemaitelly H, Yassine HM, Al-Thani MH, Al-Khal A, Abu-Raddad LJ. Associations of vaccination and of prior infection with positive PCR test results for SARS-CoV-2 in airline passengers arriving in Qatar. <em>JAMA</em> 2021;326:185-188.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r49"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2021.9970" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34106201/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000660117400002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Associations+of+vaccination+and+of+prior+infection+with+positive+PCR+test+results+for+SARS-CoV-2+in+airline+passengers+arriving+in+Qatar.&amp;publication_year=2021&amp;journal=JAMA&amp;pages=185-188&amp;doi=10.1001%2Fjama.2021.9970&amp;pmid=34106201" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">50.</div><div id="r50" class="citations"><div class="citation"><div class="citation-content">Hitchings MDT, Ranzani OT, Scaramuzzini Torres MS, et al. Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: a test-negative case-control study. April 7, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.04.07.21255081v1">https://www.medrxiv.org/content/10.1101/2021.04.07.21255081v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r52"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+CoronaVac+in+the+setting+of+high+SARS-CoV-2+P.1+variant+transmission+in+Brazil%3A+a+test-negative+case-control+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">51.</div><div id="r51" class="citations"><div class="citation"><div class="citation-content">Hunter PR, Brainard J. Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose: a reanalysis of a study of ‘real-world’ vaccination outcomes from Israel. February 3, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.02.01.21250957v1">https://www.medrxiv.org/content/10.1101/2021.02.01.21250957v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r52"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimating+the+effectiveness+of+the+Pfizer+COVID-19+BNT162b2+vaccine+after+a+single+dose%3A+a+reanalysis+of+a+study+of+%E2%80%98real-world%E2%80%99+vaccination+outcomes+from+Israel.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">52.</div><div id="r52" class="citations"><div class="citation"><div class="citation-content">Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. <em>Lancet</em> 2021;397:1725-1735.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r52"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00790-X" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33901423/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647813600027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+coverage+in+health-care+workers+in+England+and+effectiveness+of+BNT162b2+mRNA+vaccine+against+infection+%28SIREN%29%3A+a+prospective%2C+multicentre%2C+cohort+study.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=1725-1735&amp;doi=10.1016%2FS0140-6736%2821%2900790-X&amp;pmid=33901423" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">53.</div><div id="r53" class="citations"><div class="citation"><div class="citation-content">Daum RS, Siber GR, Ballanco GA, Sood SK. Serum anticapsular antibody response in the first week after immunization of adults and infants with the <i>Haemophilus influenzae</i> type b-<i>Neisseria meningitidis</i> outer membrane protein complex conjugate vaccine. <em>J Infect Dis</em> 1991;164:1154-1159.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r53" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/164.6.1154" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1955715/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1991GR66000016" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Serum+anticapsular+antibody+response+in+the+first+week+after+immunization+of+adults+and+infants+with+the+Haemophilus+influenzae+type+b-Neisseria+meningitidis+outer+membrane+protein+complex+conjugate+vaccine.&amp;publication_year=1991&amp;journal=J+Infect+Dis&amp;pages=1154-1159&amp;doi=10.1093%2Finfdis%2F164.6.1154&amp;pmid=1955715" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r53" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r53-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and other vaccines. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r53-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after vaccination or an immunologic effect. </span></a></li></ul></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/385/24"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">385</span></span> • <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">24</span></span> • <span property="datePublished">December 9, 2021</span></a></div><div class="core-elocator"><span class="heading">eLocator</span>: <span class="content" property="identifier" typeof="Text">e83</span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright © 2021 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: October 6, 2021</div><div><b class="core-label">Published in issue</b>: December 9, 2021</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/coronavirus" alt="View article keyword Coronavirus" data-interactiontype="article_recirculation_click">Coronavirus</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Hiam</span> <span property="familyName">Chemaitelly</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Patrick</span> <span property="familyName">Tang</span>, <span property="honorificSuffix">M.D., Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-1583-5484" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-1583-5484</a></span>, <span property="author" typeof="Person"><span property="givenName">Mohammad R.</span> <span property="familyName">Hasan</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Sawsan</span> <span property="familyName">AlMukdad</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Hadi M.</span> <span property="familyName">Yassine</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Fatiha M.</span> <span property="familyName">Benslimane</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Hebah A.</span> <span property="familyName">Al Khatib</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Peter</span> <span property="familyName">Coyle</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Houssein H.</span> <span property="familyName">Ayoub</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-2512-6657" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-2512-6657</a></span>, <span property="author" typeof="Person"><span property="givenName">Zaina</span> <span property="familyName">Al Kanaani</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Einas</span> <span property="familyName">Al Kuwari</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Andrew</span> <span property="familyName">Jeremijenko</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Anvar H.</span> <span property="familyName">Kaleeckal</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Ali N.</span> <span property="familyName">Latif</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Riyazuddin M.</span> <span property="familyName">Shaik</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Hanan F.</span> <span property="familyName">Abdul Rahim</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Gheyath K.</span> <span property="familyName">Nasrallah</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Mohamed G.</span> <span property="familyName">Al Kuwari</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Hamad E.</span> <span property="familyName">Al Romaihi</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Adeel A.</span> <span property="familyName">Butt</span>, <span property="honorificSuffix">M.B., B.S.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1118-1826" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1118-1826</a></span>, <span property="author" typeof="Person"><span property="givenName">Mohamed H.</span> <span property="familyName">Al-Thani</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Abdullatif</span> <span property="familyName">Al Khal</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Roberto</span> <span property="familyName">Bertollini</span>, <span property="honorificSuffix">M.D., M.P.H.</span></span>, and <span property="author" typeof="Person"><span property="givenName">Laith J.</span> <span property="familyName">Abu-Raddad</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0790-0506" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-0790-0506</a></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><span property="name">From the Infectious Disease Epidemiology Group (H.C., S.A., L.J.A.-R.) and the World Health Organization Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis (H.C., S.A., L.J.A.-R.), Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation–Education City, the Department of Pathology, Sidra Medicine (P.T., M.R.H.), the Biomedical Research Center, Member of QU Health (H.M.Y., F.M.B., H.A.A.K., P.C., G.K.N.), the Departments of Biomedical Science (H.M.Y., F.M.B., H.A.A.K., G.K.N.) and Public Health (H.F.A.R., L.J.A.-R.), College of Health Sciences, and the Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences (H.H.A.), Qatar University, Hamad Medical Corporation (P.C., Z.A.K., E.A.K., A.J., A.H.K., A.N.L., R.M.S., A.A.B., A.A.K.), Primary Health Care Corporation (M.G.A.K.), and the Ministry of Public Health (H.E.A.R., M.H.A.-T., R.B.) — all in Doha, Qatar; Wellcome–Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom (P.C.); and the Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York (A.A.B., L.J.A.-R.).</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. Abu-Raddad can be contacted at <a href="mailto:lja2002@qatar-med.cornell.edu">lja2002@qatar-med.cornell.edu</a> or at the Infectious Disease Epidemiology Group, World Health Organization Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Qatar Foundation–Education City, P.O. Box 24144, Doha, Qatar.</div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">611</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2114114" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="4297d6b1-1218-17aa-f3c6-43ab8f6635f0"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356" style="display:inline-block;">
                <img alt="Article has an altmetric score of 4051" src="https://badges.altmetric.com/?size=320&amp;score=4051&amp;types=mbvrtwfd" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_4297d6b1-1218-17aa-f3c6-43ab8f6635f0" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=news">
          Picked up by <b>105</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=blogs">
          Blogged by <b>12</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #9f79f2;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=policy-documents">
          Referenced in <b>7</b> policy sources
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=twitter">
          Posted by <b>4485</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=facebook">
          On <b>7</b> Facebook pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #958899;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=wikipedia">
          Referenced in <b>5</b> Wikipedia pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=reddit">
          Reddited by <b>4</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #94DB5E;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=114633356&amp;tab=video">
          On <b>5</b> videos
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>459</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d6aed105070292-SJC"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2114114"> <input type="hidden" name="downloadFileName" value="csp_385_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2021.385.issue-24%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2114114%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="611" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Benjamin Steinegger, </li><li class="list-inline-item cited-by__entry__author">Giulio Burgio, </li><li class="list-inline-item cited-by__entry__author">Piergiorgio Castioni, </li><li class="list-inline-item cited-by__entry__author">Clara Granell, </li><li class="list-inline-item cited-by__entry__author">Alex Arenas, </li></ul><span class="cited-by__entry__title">The spread of the Delta variant in Catalonia during summer 2021: Modelling and interpretation, </span><span class="cited-by__entry__series-title">Journal of Infection and Public Health, </span><span class="cited-by__entry__volume"><strong>18</strong>, </span><span class="cited-by__entry__issue">7, </span><span class="cited-by__entry__page-range">(102771), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jiph.2025.102771" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jiph.2025.102771</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jiph.2025.102771" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Hiam Chemaitelly, </li><li class="list-inline-item cited-by__entry__author">Houssein H Ayoub, </li><li class="list-inline-item cited-by__entry__author">Peter Coyle, </li><li class="list-inline-item cited-by__entry__author">Patrick Tang, </li><li class="list-inline-item cited-by__entry__author">Mohammad R Hasan, </li><li class="list-inline-item cited-by__entry__author">Hadi M Yassine, </li><li class="list-inline-item cited-by__entry__author">Asmaa A Al Thani, </li><li class="list-inline-item cited-by__entry__author">Zaina Al-Kanaani, </li><li class="list-inline-item cited-by__entry__author">Einas Al-Kuwari, </li><li class="list-inline-item cited-by__entry__author">Andrew Jeremijenko, </li><li class="list-inline-item cited-by__entry__author">Anvar Hassan Kaleeckal, </li><li class="list-inline-item cited-by__entry__author">Ali Nizar Latif, </li><li class="list-inline-item cited-by__entry__author">Riyazuddin Mohammad Shaik, </li><li class="list-inline-item cited-by__entry__author">Hanan F Abdul-Rahim, </li><li class="list-inline-item cited-by__entry__author">Gheyath K Nasrallah, </li><li class="list-inline-item cited-by__entry__author">Mohamed Ghaith Al-Kuwari, </li><li class="list-inline-item cited-by__entry__author">Hamad Eid Al-Romaihi, </li><li class="list-inline-item cited-by__entry__author">Mohamed H Al-Thani, </li><li class="list-inline-item cited-by__entry__author">Abdullatif Al-Khal, </li><li class="list-inline-item cited-by__entry__author">Roberto Bertollini, </li><li class="list-inline-item cited-by__entry__author">Adeel A Butt, </li><li class="list-inline-item cited-by__entry__author">Laith J Abu-Raddad, </li></ul><span class="cited-by__entry__title">Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar, </span><span class="cited-by__entry__series-title">eLife, </span><span class="cited-by__entry__volume"><strong>14</strong>, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.7554/eLife.103690" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.7554/eLife.103690</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.7554/eLife.103690" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Yuki Furuse, </li><li class="list-inline-item cited-by__entry__author">Takahiro Tabuchi, </li></ul><span class="cited-by__entry__title">Impact of COVID-19 vaccination by implementation timing and coverage rate in relation to misinformation prevalence in Japan, </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>59</strong>, </span><span class="cited-by__entry__page-range">(127273), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.127273" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.127273</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.127273" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Zahra Hasan, </li><li class="list-inline-item cited-by__entry__author">Kiran Iqbal Masood, </li><li class="list-inline-item cited-by__entry__author">Shama Qaiser, </li><li class="list-inline-item cited-by__entry__author">Akbar Kanji, </li><li class="list-inline-item cited-by__entry__author">Fridah Mwenda, </li><li class="list-inline-item cited-by__entry__author">Marta Alenquer, </li><li class="list-inline-item cited-by__entry__author">Junaid Iqbal, </li><li class="list-inline-item cited-by__entry__author">Filipe Ferreira, </li><li class="list-inline-item cited-by__entry__author">Yaqub Wassan, </li><li class="list-inline-item cited-by__entry__author">Sadaf Balouch, </li><li class="list-inline-item cited-by__entry__author">Maliha Yameen, </li><li class="list-inline-item cited-by__entry__author">Shahneel Hussain, </li><li class="list-inline-item cited-by__entry__author">Kehkashan Begum, </li><li class="list-inline-item cited-by__entry__author">Khalid Feroz, </li><li class="list-inline-item cited-by__entry__author">Sajid Muhammad, </li><li class="list-inline-item cited-by__entry__author">Ayesha Sadiqa, </li><li class="list-inline-item cited-by__entry__author">Mishgan Akhtar, </li><li class="list-inline-item cited-by__entry__author">Atif Habib, </li><li class="list-inline-item cited-by__entry__author">Syed Muhammad Areeb Ahmed, </li><li class="list-inline-item cited-by__entry__author">Afsar Ali Mian, </li><li class="list-inline-item cited-by__entry__author">Rabia Hussain, </li><li class="list-inline-item cited-by__entry__author">Maria Joao Amorim, </li><li class="list-inline-item cited-by__entry__author">Zulfiqar A. Bhutta, </li></ul><span class="cited-by__entry__title">Comparative study of humoral and cellular immunity against SARS-CoV-2 induced by different COVID-19 vaccine types: Insights into protection against wildtype, Delta and JN.1 omicron strains, </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>59</strong>, </span><span class="cited-by__entry__page-range">(127270), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.127270" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.127270</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.127270" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Chang Liu, </li><li class="list-inline-item cited-by__entry__author">Tim K. Tsang, </li><li class="list-inline-item cited-by__entry__author">Sheena G. Sullivan, </li><li class="list-inline-item cited-by__entry__author">Benjamin J. Cowling, </li><li class="list-inline-item cited-by__entry__author">Bingyi Yang, </li></ul><span class="cited-by__entry__title">Comparative duration of neutralizing responses and protections of COVID-19 vaccination and correlates of protection, </span><span class="cited-by__entry__series-title">Nature Communications, </span><span class="cited-by__entry__volume"><strong>16</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1038/s41467-025-60024-9" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1038/s41467-025-60024-9</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1038/s41467-025-60024-9" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Xiao-Qiang Liu, </li><li class="list-inline-item cited-by__entry__author">Yang-Yang Qi, </li><li class="list-inline-item cited-by__entry__author">Tao Huang, </li><li class="list-inline-item cited-by__entry__author">Li-Li Huang, </li><li class="list-inline-item cited-by__entry__author">Ming-Xuan Zhao, </li><li class="list-inline-item cited-by__entry__author">Zhong-Fang Wang, </li><li class="list-inline-item cited-by__entry__author">Jun Dai, </li><li class="list-inline-item cited-by__entry__author">Yan-Xia Wang, </li><li class="list-inline-item cited-by__entry__author">Jing-Jing Chen, </li><li class="list-inline-item cited-by__entry__author">Xiao-Yun Yang, </li><li class="list-inline-item cited-by__entry__author">Hui-Lan Fan, </li><li class="list-inline-item cited-by__entry__author">Xue-Mei Yan, </li><li class="list-inline-item cited-by__entry__author">Jian-Chang He, </li><li class="list-inline-item cited-by__entry__author">Yan-Xiang Zou, </li><li class="list-inline-item cited-by__entry__author">Zhi-Wei Jiang, </li><li class="list-inline-item cited-by__entry__author">Zhi-Fei Zhan, </li><li class="list-inline-item cited-by__entry__author">Si-Wen Tao, </li><li class="list-inline-item cited-by__entry__author">De-Fang Dai, </li><li class="list-inline-item cited-by__entry__author">Feng Shi, </li><li class="list-inline-item cited-by__entry__author">Qiong-Na Zhang, </li><li class="list-inline-item cited-by__entry__author">Xiu-Liang Yang, </li><li class="list-inline-item cited-by__entry__author">Xiao-Zhong Li, </li><li class="list-inline-item cited-by__entry__author">Wei Li, </li><li class="list-inline-item cited-by__entry__author">Jing Lu, </li><li class="list-inline-item cited-by__entry__author">Jiang-Bing Zheng, </li><li class="list-inline-item cited-by__entry__author">Zhi-Hua Zhang, </li><li class="list-inline-item cited-by__entry__author">Gao-Xiang Chen, </li><li class="list-inline-item cited-by__entry__author">Hong Su, </li><li class="list-inline-item cited-by__entry__author">Wei-Min Gao, </li><li class="list-inline-item cited-by__entry__author">Lorenz von Seidlein, </li><li class="list-inline-item cited-by__entry__author">Xuan-Yi Wang, </li><li class="list-inline-item cited-by__entry__author">Lin Yuan, </li><li class="list-inline-item cited-by__entry__author">Jin-Zhong Lin, </li></ul><span class="cited-by__entry__title">Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial, </span><span class="cited-by__entry__series-title">Human Vaccines &amp; Immunotherapeutics, </span><span class="cited-by__entry__volume"><strong>21</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1080/21645515.2025.2502250" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1080/21645515.2025.2502250</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1080/21645515.2025.2502250" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Lanyue Zhang, </li><li class="list-inline-item cited-by__entry__author">Lei Yang, </li><li class="list-inline-item cited-by__entry__author">Wuping Zhou, </li><li class="list-inline-item cited-by__entry__author">Weiyan Jian, </li></ul><span class="cited-by__entry__title">The protective effect of emergency fourth-dose vaccination issued to county-level hospital nurses against the Omicron infection peak: evidence from China, </span><span class="cited-by__entry__series-title">BMC Nursing, </span><span class="cited-by__entry__volume"><strong>24</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1186/s12912-025-03172-z" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1186/s12912-025-03172-z</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1186/s12912-025-03172-z" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Elizabeth B. Amona, </li><li class="list-inline-item cited-by__entry__author">Indranil Sahoo, </li><li class="list-inline-item cited-by__entry__author">Edward L. Boone, </li><li class="list-inline-item cited-by__entry__author">Ryad Ghanam, </li></ul><span class="cited-by__entry__title">Studying Disease Reinfection Rates, Vaccine Efficacy, and the Timing of Vaccine Rollout in the Context of Infectious Diseases: A COVID-19 Case Study, </span><span class="cited-by__entry__series-title">International Journal of Environmental Research and Public Health, </span><span class="cited-by__entry__volume"><strong>22</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(731), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/ijerph22050731" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/ijerph22050731</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/ijerph22050731" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Tobias Monschein, </li><li class="list-inline-item cited-by__entry__author">Tobias Zrzavy, </li><li class="list-inline-item cited-by__entry__author">Paulus S. Rommer, </li><li class="list-inline-item cited-by__entry__author">Sven G. Meuth, </li><li class="list-inline-item cited-by__entry__author">Andrew Chan, </li><li class="list-inline-item cited-by__entry__author">Thomas Berger, </li><li class="list-inline-item cited-by__entry__author">Hans-Peter Hartung, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 Vaccines and Multiple Sclerosis, </span><span class="cited-by__entry__series-title">Neurology Neuroimmunology &amp; Neuroinflammation, </span><span class="cited-by__entry__volume"><strong>12</strong>, </span><span class="cited-by__entry__issue">3, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1212/NXI.0000000000200393" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1212/NXI.0000000000200393</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1212/NXI.0000000000200393" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Hamad Eid Al-Romaihi, </li><li class="list-inline-item cited-by__entry__author">Rayane El-Khoury, </li><li class="list-inline-item cited-by__entry__author">Sayed Himatt, </li><li class="list-inline-item cited-by__entry__author">Moutaz F. M. Derbala, </li><li class="list-inline-item cited-by__entry__author">Amjad Mohammed Idries, </li><li class="list-inline-item cited-by__entry__author">Abid Saeed, </li><li class="list-inline-item cited-by__entry__author">Maysa Kamal Abdelmageed, </li><li class="list-inline-item cited-by__entry__author">Khalid Hamid Elawad, </li><li class="list-inline-item cited-by__entry__author">Merin Alex, </li><li class="list-inline-item cited-by__entry__author">Mohamed Sallam, </li><li class="list-inline-item cited-by__entry__author">Maha Hammam Al-Shamali, </li><li class="list-inline-item cited-by__entry__author">Peter Coyle, </li><li class="list-inline-item cited-by__entry__author">Saad Alkaabi, </li><li class="list-inline-item cited-by__entry__author">Hiam Chemaitelly, </li><li class="list-inline-item cited-by__entry__author">Devendra Bansal, </li><li class="list-inline-item cited-by__entry__author">Laith J. Abu-Raddad, </li></ul><span class="cited-by__entry__title">Prevalence of hepatitis C virus infection in Qatar’s resident population based on a national screening campaign, </span><span class="cited-by__entry__series-title">Scientific Reports, </span><span class="cited-by__entry__volume"><strong>15</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1038/s41598-025-96722-z" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1038/s41598-025-96722-z</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1038/s41598-025-96722-z" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2021.385.issue-24%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2114114%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2114114" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2114114" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2114114.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f1.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/21755fa7-b76f-4b1d-a183-00d2ea09ea80/assets/images/large/nejmoa2114114_f1.jpg" height="3438" width="2315" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Time Trend of Vaccinated Persons, SARS-CoV-2 Infections, and Vaccine Breakthrough Infections in Qatar.</div><div class="notes"><div role="doc-footnote">SARS-CoV-2 denotes severe acute respiratory syndrome coronavirus 2.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f2.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/d0c3ffb2-c5cc-4dc7-9cf2-68d68a8a241e/assets/images/large/nejmoa2114114_f2.jpg" height="3037" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine.</div><div class="notes"><div role="doc-footnote">Data are presented as effectiveness point estimates, with 𝙸 bars indicating the corresponding 95% confidence intervals. Covid-19 denotes coronavirus disease 2019.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2114114/asset/2d422ab1-a140-4299-8a82-3b4f1ef4e059/assets/images/large/nejmoa2114114_t1.jpg" height="2322" width="2615" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Characteristics</th><th class="txxx-borders" colspan="2"><span>0–13 Days after First Dose</span></th><th class="txxx-borders" colspan="2"><span>≥14 Days after First Dose and No Second Dose</span></th><th class="txxr-borders" colspan="2"><span>First Month after Second Dose</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Case Participants:<br>PCR-Positive<br>(N=115,326)</th><th class="xxxx-borders">Controls:<br>PCR-Negative<br>(N=115,326)</th><th class="xxxx-borders">Case Participants:<br>PCR-Positive<br>(N=113,830)</th><th class="xxxx-borders">Controls:<br>PCR-Negative<br>(N=113,830)</th><th class="xxxx-borders">Case Participants:<br>PCR-Positive<br>(N=115,913)</th><th class="xxxr-borders">Controls:<br>PCR-Negative<br>(N=115,913)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Median age (IQR) — yr</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxx-borders shading">31 (21–39)</td><td class="xxxr-borders shading">31 (22–39)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Age group — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">&lt;20 yr</td><td class="xxxx-borders shading">26,915 (23.3)</td><td class="xxxx-borders shading">26,915 (23.3)</td><td class="xxxx-borders shading">26,813 (23.6)</td><td class="xxxx-borders shading">26,813 (23.6)</td><td class="xxxx-borders shading">26,822 (23.1)</td><td class="xxxr-borders shading">26,822 (23.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">20–29 yr</td><td class="xxxx-borders">24,879 (21.6)</td><td class="xxxx-borders">24,879 (21.6)</td><td class="xxxx-borders">24,567 (21.6)</td><td class="xxxx-borders">24,567 (21.6)</td><td class="xxxx-borders">24,770 (21.4)</td><td class="xxxr-borders">24,770 (21.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">30–39 yr</td><td class="xxxx-borders shading">36,749 (31.9)</td><td class="xxxx-borders shading">36,749 (31.9)</td><td class="xxxx-borders shading">36,150 (31.8)</td><td class="xxxx-borders shading">36,150 (31.8)</td><td class="xxxx-borders shading">36,896 (31.8)</td><td class="xxxr-borders shading">36,896 (31.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">40–49 yr</td><td class="xxxx-borders">19,154 (16.6)</td><td class="xxxx-borders">19,154 (16.6)</td><td class="xxxx-borders">18,820 (16.5)</td><td class="xxxx-borders">18,820 (16.5)</td><td class="xxxx-borders">19,382 (16.7)</td><td class="xxxr-borders">19,382 (16.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">50–59 yr</td><td class="xxxx-borders shading">6,083 (5.3)</td><td class="xxxx-borders shading">6,083 (5.3)</td><td class="xxxx-borders shading">5,959 (5.2)</td><td class="xxxx-borders shading">5,959 (5.2)</td><td class="xxxx-borders shading">6,350 (5.5)</td><td class="xxxr-borders shading">6,350 (5.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">60–69 yr</td><td class="xxxx-borders">1,229 (1.1)</td><td class="xxxx-borders">1,229 (1.1)</td><td class="xxxx-borders">1,195 (1.0)</td><td class="xxxx-borders">1,195 (1.0)</td><td class="xxxx-borders">1,326 (1.1)</td><td class="xxxr-borders">1,326 (1.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">≥70 yr</td><td class="xxxx-borders shading">317 (0.3)</td><td class="xxxx-borders shading">317 (0.3)</td><td class="xxxx-borders shading">326 (0.3)</td><td class="xxxx-borders shading">326 (0.3)</td><td class="xxxx-borders shading">367 (0.3)</td><td class="xxxr-borders shading">367 (0.3)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Sex</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Male</td><td class="xxxx-borders shading">79,255 (68.7)</td><td class="xxxx-borders shading">79,255 (68.7)</td><td class="xxxx-borders shading">78,148 (68.7)</td><td class="xxxx-borders shading">78,148 (68.7)</td><td class="xxxx-borders shading">79,750 (68.8)</td><td class="xxxr-borders shading">79,750 (68.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Female</td><td class="xxxx-borders">36,071 (31.3)</td><td class="xxxx-borders">36,071 (31.3)</td><td class="xxxx-borders">35,682 (31.3)</td><td class="xxxx-borders">35,682 (31.3)</td><td class="xxxx-borders">36,163 (31.2)</td><td class="xxxr-borders">36,163 (31.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Nationality<a href="#core-t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Bangladeshi</td><td class="xxxx-borders">8,323 (7.2)</td><td class="xxxx-borders">8,323 (7.2)</td><td class="xxxx-borders">8,229 (7.2)</td><td class="xxxx-borders">8,229 (7.2)</td><td class="xxxx-borders">8,326 (7.2)</td><td class="xxxr-borders">8,326 (7.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Egyptian</td><td class="xxxx-borders shading">6,734 (5.8)</td><td class="xxxx-borders shading">6,734 (5.8)</td><td class="xxxx-borders shading">6,629 (5.8)</td><td class="xxxx-borders shading">6,629 (5.8)</td><td class="xxxx-borders shading">6,859 (5.9)</td><td class="xxxr-borders shading">6,859 (5.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Filipino</td><td class="xxxx-borders">10,713 (9.3)</td><td class="xxxx-borders">10,713 (9.3)</td><td class="xxxx-borders">10,535 (9.3)</td><td class="xxxx-borders">10,535 (9.3)</td><td class="xxxx-borders">10,674 (9.2)</td><td class="xxxr-borders">10,674 (9.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Indian</td><td class="xxxx-borders shading">29,914 (25.9)</td><td class="xxxx-borders shading">29,914 (25.9)</td><td class="xxxx-borders shading">29,536 (25.9)</td><td class="xxxx-borders shading">29,536 (25.9)</td><td class="xxxx-borders shading">30,325 (26.2)</td><td class="xxxr-borders shading">30,325 (26.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Nepalese</td><td class="xxxx-borders">10,505 (9.1)</td><td class="xxxx-borders">10,505 (9.1)</td><td class="xxxx-borders">10,367 (9.1)</td><td class="xxxx-borders">10,367 (9.1)</td><td class="xxxx-borders">10,496 (9.1)</td><td class="xxxr-borders">10,496 (9.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Pakistani</td><td class="xxxx-borders shading">5,793 (5.0)</td><td class="xxxx-borders shading">5,793 (5.0)</td><td class="xxxx-borders shading">5,735 (5.0)</td><td class="xxxx-borders shading">5,735 (5.0)</td><td class="xxxx-borders shading">5,837 (5.0)</td><td class="xxxr-borders shading">5,837 (5.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Qatari</td><td class="xxxx-borders">17,375 (15.1)</td><td class="xxxx-borders">17,375 (15.1)</td><td class="xxxx-borders">17,087 (15.0)</td><td class="xxxx-borders">17,087 (15.0)</td><td class="xxxx-borders">17,147 (14.8)</td><td class="xxxr-borders">17,147 (14.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Sri Lankan</td><td class="xxxx-borders shading">3,756 (3.3)</td><td class="xxxx-borders shading">3,756 (3.3)</td><td class="xxxx-borders shading">3,732 (3.3)</td><td class="xxxx-borders shading">3,732 (3.3)</td><td class="xxxx-borders shading">3,784 (3.3)</td><td class="xxxr-borders shading">3,784 (3.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Sudanese</td><td class="xxxx-borders">3,249 (2.8)</td><td class="xxxx-borders">3,249 (2.8)</td><td class="xxxx-borders">3,242 (2.8)</td><td class="xxxx-borders">3,242 (2.8)</td><td class="xxxx-borders">3,285 (2.8)</td><td class="xxxr-borders">3,285 (2.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Other nationalities<a href="#core-t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders shading">18,964 (16.4)</td><td class="xxxx-borders shading">18,964 (16.4)</td><td class="xxxx-borders shading">18,738 (16.5)</td><td class="xxxx-borders shading">18,738 (16.5)</td><td class="xxxx-borders shading">19,180 (16.5)</td><td class="xxxr-borders shading">19,180 (16.5)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Reason for PCR testing</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Clinical suspicion</td><td class="xxxx-borders shading">40,768 (35.4)</td><td class="xxxx-borders shading">40,768 (35.4)</td><td class="xxxx-borders shading">40,261 (35.4)</td><td class="xxxx-borders shading">40,261 (35.4)</td><td class="xxxx-borders shading">41,138 (35.5)</td><td class="xxxr-borders shading">41,138 (35.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Contact tracing</td><td class="xxxx-borders">18,772 (16.3)</td><td class="xxxx-borders">18,772 (16.3)</td><td class="xxxx-borders">18,481 (16.2)</td><td class="xxxx-borders">18,481 (16.2)</td><td class="xxxx-borders">18,666 (16.1)</td><td class="xxxr-borders">18,666 (16.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Routine health care testing</td><td class="xxxx-borders shading">14,479 (12.6)</td><td class="xxxx-borders shading">14,479 (12.6)</td><td class="xxxx-borders shading">14,351 (12.6)</td><td class="xxxx-borders shading">14,351 (12.6)</td><td class="xxxx-borders shading">14,536 (12.5)</td><td class="xxxr-borders shading">14,536 (12.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Survey</td><td class="xxxx-borders">27,972 (24.3)</td><td class="xxxx-borders">27,972 (24.3)</td><td class="xxxx-borders">27,484 (24.1)</td><td class="xxxx-borders">27,484 (24.1)</td><td class="xxxx-borders">27,883 (24.1)</td><td class="xxxr-borders">27,883 (24.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Individual request</td><td class="xxxx-borders shading">12,914 (11.2)</td><td class="xxxx-borders shading">12,914 (11.2)</td><td class="xxxx-borders shading">12,838 (11.3)</td><td class="xxxx-borders shading">12,838 (11.3)</td><td class="xxxx-borders shading">13,233 (11.4)</td><td class="xxxr-borders shading">13,233 (11.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">Other</td><td class="xbxx-borders">421 (0.4)</td><td class="xbxx-borders">421 (0.4)</td><td class="xbxx-borders">415 (0.4)</td><td class="xbxx-borders">415 (0.4)</td><td class="xbxx-borders">457 (0.4)</td><td class="xbxr-borders">457 (0.4)</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"></a><div class="notes"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"><div class="label">*</div></a><div id="core-t1fn1" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg">Data for other time-since-vaccination analyses are shown in Tables S2 and S3 in the </a><a href="#ap1">Supplementary Appendix</a>. Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for polymerase-chain-reaction (PCR) testing, and calendar week of PCR test. Percentages may not total 100 because of rounding. IQR denotes interquartile range.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">Nationalities were chosen to represent the most populous groups in Qatar.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t1fn3" role="paragraph" data-to-manipulate="true">The category of other nationalities includes 108 other nationalities in Qatar for 0 to 13 days after the first dose, 106 other nationalities for 14 or more days after the first dose and no second dose, and 108 other nationalities for the first month after the second dose.</div></div></div></figcaption><figcaption><div class="caption">Demographic Characteristics of the Participants and Reasons for PCR Testing among Samples Used to Estimate BNT162b2 Vaccine Effectiveness.<a href="#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t2"><figure class="table"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2114114/asset/7d8ee96f-212b-49bc-bec9-1906762e27e7/assets/images/large/nejmoa2114114_t2.jpg" height="1694" width="2615" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Substudies<a href="#core-t2fn2" role="doc-noteref">†</a></th><th class="txxx-borders" colspan="5"><span>Effectiveness against Infection</span></th><th class="txxr-borders" colspan="5"><span>Effectiveness against Hospitalization and Death</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#core-t2fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#core-t2fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders">Effectiveness % (95% CI)<a href="#core-t2fn4" role="doc-noteref">§</a></th><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>Severe, Critical, or Fatal Disease<a href="#core-t2fn3" role="doc-noteref">‡</a><a href="#core-t2fn5" role="doc-noteref">¶</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#core-t2fn3" role="doc-noteref">‡</a></span></th><th class="xxxr-borders">Effectiveness % (95% CI)<a href="#core-t2fn4" role="doc-noteref">§</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">0–13 Days after first dose</td><td class="xxxx-borders shading">4228</td><td class="xxxx-borders shading">111,098</td><td class="xxxx-borders shading">4053</td><td class="xxxx-borders shading">111,273</td><td class="xxxx-borders shading">−4.9<br>(−9.8 to −0.2)</td><td class="xxxx-borders shading">245</td><td class="xxxx-borders shading">4001</td><td class="xxxx-borders shading">286</td><td class="xxxx-borders shading">3960</td><td class="xxxr-borders shading">16.1<br>(−0.6 to 30.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">≥14 Days after first dose and no second dose</td><td class="xxxx-borders">2358</td><td class="xxxx-borders">111,472</td><td class="xxxx-borders">3567</td><td class="xxxx-borders">110,263</td><td class="xxxx-borders">36.8<br>(33.2 to 40.2)</td><td class="xxxx-borders">102</td><td class="xxxx-borders">4032</td><td class="xxxx-borders">272</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">66.1<br>(56.8 to 73.5)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Month after second dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">1</td><td class="xxxx-borders">2915</td><td class="xxxx-borders">112,998</td><td class="xxxx-borders">9986</td><td class="xxxx-borders">105,927</td><td class="xxxx-borders">77.5<br>(76.4 to 78.6)</td><td class="xxxx-borders">32</td><td class="xxxx-borders">4082</td><td class="xxxx-borders">585</td><td class="xxxx-borders">3529</td><td class="xxxr-borders">96.0<br>(93.9 to 97.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">2</td><td class="xxxx-borders shading">1450</td><td class="xxxx-borders shading">111,874</td><td class="xxxx-borders shading">4304</td><td class="xxxx-borders shading">109,020</td><td class="xxxx-borders shading">73.2<br>(71.3 to 75.0)</td><td class="xxxx-borders shading">23</td><td class="xxxx-borders shading">4062</td><td class="xxxx-borders shading">323</td><td class="xxxx-borders shading">3762</td><td class="xxxr-borders shading">96.8<br>(93.9 to 98.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">3</td><td class="xxxx-borders">800</td><td class="xxxx-borders">111,388</td><td class="xxxx-borders">2128</td><td class="xxxx-borders">110,060</td><td class="xxxx-borders">69.6<br>(66.7 to 72.3)</td><td class="xxxx-borders">17</td><td class="xxxx-borders">4026</td><td class="xxxx-borders">181</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">94.3<br>(89.1 to 97.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">4</td><td class="xxxx-borders shading">492</td><td class="xxxx-borders shading">111,070</td><td class="xxxx-borders shading">856</td><td class="xxxx-borders shading">110,706</td><td class="xxxx-borders shading">51.7<br>(45.0 to 57.6)</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">3996</td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">3955</td><td class="xxxr-borders shading">83.7<br>(65.5 to 92.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">5</td><td class="xxxx-borders">548</td><td class="xxxx-borders">110,991</td><td class="xxxx-borders">646</td><td class="xxxx-borders">110,893</td><td class="xxxx-borders">22.5<br>(10.6 to 32.7)</td><td class="xxxx-borders">0</td><td class="xxxx-borders">3990</td><td class="xxxx-borders">33</td><td class="xxxx-borders">3957</td><td class="xxxr-borders">100.0<a href="#core-t2fn6" role="doc-noteref">‖</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">6</td><td class="xxxx-borders shading">460</td><td class="xxxx-borders shading">111,007</td><td class="xxxx-borders shading">512</td><td class="xxxx-borders shading">110,955</td><td class="xxxx-borders shading">17.3<br>(2.2 to 30.1)</td><td class="xxxx-borders shading">8</td><td class="xxxx-borders shading">3988</td><td class="xxxx-borders shading">24</td><td class="xxxx-borders shading">3972</td><td class="xxxr-borders shading">88.9<br>(52.1 to 97.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">≥7</td><td class="xbxx-borders">135</td><td class="xbxx-borders">110,942</td><td class="xbxx-borders">162</td><td class="xbxx-borders">110,915</td><td class="xbxx-borders">22.3<br>(−1.7 to 40.7)</td><td class="xbxx-borders">6</td><td class="xbxx-borders">3983</td><td class="xbxx-borders">11</td><td class="xbxx-borders">3978</td><td class="xbxr-borders">55.6<br>(−44.3 to 86.3)</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"></a><div class="notes"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t2fn1" role="paragraph" data-to-manipulate="true">Covid-19 denotes coronavirus disease 2019, and SARS-CoV-2 severe acute respiratory syndrome coronavirus 2.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t2fn2" role="paragraph" data-to-manipulate="true">In each analysis for a specific time-since-vaccination stratum, we included only participants vaccinated in this specific time-since-vaccination stratum and those unvaccinated. Only matched pairs of PCR-positive and PCR-negative persons, in which both members of the pair were either unvaccinated or fell within each time-since-vaccination stratum, were included in the corresponding estimate of vaccine effectiveness. Thus, the number of case participants (and controls) varied across time-since-vaccination analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t2fn3" role="paragraph" data-to-manipulate="true">Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for PCR testing, and calendar week of PCR test.</div></div></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"><div class="label">§</div></a><div id="core-t2fn4" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg">Vaccine effectiveness was estimated with the use of the test-negative, case–control study design.<sup></sup></a><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="core-body-ref-r12-5" href-manipulated="true" data-to-manipulate="false">11,12</a></div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="core-t2fn5" role="paragraph" data-to-manipulate="true">Severity,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="core-body-ref-r21-7" href-manipulated="true" aria-label="Reference 21" data-to-manipulate="false">21</a></sup> criticality,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="core-body-ref-r21-8" href-manipulated="true" aria-label="Reference 21" data-to-manipulate="false">21</a></sup> and fatality<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="core-body-ref-r22-4" href-manipulated="true" aria-label="Reference 22" data-to-manipulate="false">22</a></sup> were defined according to World Health Organization guidelines.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="core-t2fn6" role="paragraph" data-to-manipulate="true">The confidence interval could not be estimated because there were zero events among vaccinated participants.</div></div></div></figcaption><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine against Any SARS-CoV-2 Infection and against Any Severe, Critical, or Fatal Case of Covid-19.<a href="#core-t2fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t2"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t3"><figure class="table"><a class="open-in-viewer" href="#t3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2114114/asset/7ed1a812-a7da-4aea-af43-8a51d53b4980/assets/images/large/nejmoa2114114_t3.jpg" height="1732" width="2615" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Substudies<a href="#core-t3fn2" role="doc-noteref">†</a></th><th class="txxx-borders" colspan="5"><span>Effectiveness against Infection</span></th><th class="txxr-borders" colspan="5"><span>Effectiveness against Hospitalization and Death</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#core-t3fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#core-t3fn3" role="doc-noteref">‡</a></span></th><th class="xxxx-borders">Effectiveness % (95% CI)<a href="#core-t3fn4" role="doc-noteref">§</a></th><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>Severe, Critical, or Fatal Disease<a href="#core-t3fn3" role="doc-noteref">‡</a><a href="#core-t3fn5" role="doc-noteref">¶</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#core-t3fn3" role="doc-noteref">‡</a></span></th><th class="xxxr-borders">Effectiveness % (95% CI)<a href="#core-t3fn4" role="doc-noteref">§</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">0–13 Days after first dose</td><td class="xxxx-borders shading">4228</td><td class="xxxx-borders shading">111,098</td><td class="xxxx-borders shading">4053</td><td class="xxxx-borders shading">111,273</td><td class="xxxx-borders shading">−11.9<br>(−17.3 to −6.7)</td><td class="xxxx-borders shading">245</td><td class="xxxx-borders shading">4001</td><td class="xxxx-borders shading">286</td><td class="xxxx-borders shading">3960</td><td class="xxxr-borders shading">7.5<br>(−11.9 to 23.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">≥14 Days after first dose and no second dose</td><td class="xxxx-borders">2358</td><td class="xxxx-borders">111,472</td><td class="xxxx-borders">3567</td><td class="xxxx-borders">110,263</td><td class="xxxx-borders">32.2<br>(28.2 to 35.9)</td><td class="xxxx-borders">102</td><td class="xxxx-borders">4032</td><td class="xxxx-borders">272</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">65.0<br>(55.0 to 72.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Month after second dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">1</td><td class="xxxx-borders">2915</td><td class="xxxx-borders">112,998</td><td class="xxxx-borders">9986</td><td class="xxxx-borders">105,927</td><td class="xxxx-borders">75.8<br>(74.6 to 77.0)</td><td class="xxxx-borders">32</td><td class="xxxx-borders">4082</td><td class="xxxx-borders">585</td><td class="xxxx-borders">3529</td><td class="xxxr-borders">95.9<br>(93.6 to 97.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">2</td><td class="xxxx-borders shading">1450</td><td class="xxxx-borders shading">111,874</td><td class="xxxx-borders shading">4304</td><td class="xxxx-borders shading">109,020</td><td class="xxxx-borders shading">69.7<br>(67.4 to 71.8)</td><td class="xxxx-borders shading">23</td><td class="xxxx-borders shading">4062</td><td class="xxxx-borders shading">323</td><td class="xxxx-borders shading">3762</td><td class="xxxr-borders shading">96.3<br>(92.9 to 98.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">3</td><td class="xxxx-borders">800</td><td class="xxxx-borders">111,388</td><td class="xxxx-borders">2128</td><td class="xxxx-borders">110,060</td><td class="xxxx-borders">63.7<br>(59.9 to 67.1)</td><td class="xxxx-borders">17</td><td class="xxxx-borders">4026</td><td class="xxxx-borders">181</td><td class="xxxx-borders">3862</td><td class="xxxr-borders">93.4<br>(87.5 to 96.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">4</td><td class="xxxx-borders shading">492</td><td class="xxxx-borders shading">111,070</td><td class="xxxx-borders shading">856</td><td class="xxxx-borders shading">110,706</td><td class="xxxx-borders shading">39.1<br>(29.9 to 47.0)</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">3996</td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">3955</td><td class="xxxr-borders shading">80.8<br>(56.9 to 91.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">5</td><td class="xxxx-borders">548</td><td class="xxxx-borders">110,991</td><td class="xxxx-borders">646</td><td class="xxxx-borders">110,893</td><td class="xxxx-borders">11.4<br>(−3.5 to 24.1)</td><td class="xxxx-borders">0</td><td class="xxxx-borders">3990</td><td class="xxxx-borders">33</td><td class="xxxx-borders">3957</td><td class="xxxr-borders">100.0<a href="#core-t3fn6" role="doc-noteref">‖</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">6</td><td class="xxxx-borders shading">460</td><td class="xxxx-borders shading">111,007</td><td class="xxxx-borders shading">512</td><td class="xxxx-borders shading">110,955</td><td class="xxxx-borders shading">9.2<br>(−9.1 to 24.5)</td><td class="xxxx-borders shading">8</td><td class="xxxx-borders shading">3988</td><td class="xxxx-borders shading">24</td><td class="xxxx-borders shading">3972</td><td class="xxxr-borders shading">81.8<br>(18.5 to 95.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">≥7</td><td class="xbxx-borders">135</td><td class="xbxx-borders">110,942</td><td class="xbxx-borders">162</td><td class="xbxx-borders">110,915</td><td class="xbxx-borders">−4.4<br>(−41.3 to 22.9)</td><td class="xbxx-borders">6</td><td class="xbxx-borders">3983</td><td class="xbxx-borders">11</td><td class="xbxx-borders">3978</td><td class="xbxr-borders">44.1<br>(−86.5 to 83.3)</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="#t3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"></a><div class="notes"><a class="open-in-viewer" href="#t3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t3fn1" role="paragraph" data-to-manipulate="true">Shown is the effectiveness of the BNT162b2 vaccine against any SARS-CoV-2 infection and against any severe, critical, or fatal case of COVID-19 after adjustment for previous infection and health care worker status.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t3fn2" role="paragraph" data-to-manipulate="true">In each analysis for a specific time-since-vaccination stratum, we included only participants vaccinated in this specific time-since-vaccination stratum and those unvaccinated. Only matched pairs of PCR-positive and PCR-negative persons, in which both members of the pair were either unvaccinated or fell within each time-since-vaccination stratum, were included in the corresponding estimate of vaccine effectiveness. Thus, the number of case participants (and controls) varied across time-since-vaccination analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t3fn3" role="paragraph" data-to-manipulate="true">Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for PCR testing, and calendar week of PCR test.</div></div></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="#t3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"><div class="label">§</div></a><div id="core-t3fn4" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="#t3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg">Vaccine effectiveness was estimated with the use of the test-negative, case–control study design.<sup></sup></a><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="core-body-ref-r12-6" href-manipulated="true" data-to-manipulate="false">11,12</a></div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="core-t3fn5" role="paragraph" data-to-manipulate="true">Severity,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="core-body-ref-r21-9" href-manipulated="true" aria-label="Reference 21" data-to-manipulate="false">21</a></sup> criticality,<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="core-body-ref-r21-10" href-manipulated="true" aria-label="Reference 21" data-to-manipulate="false">21</a></sup> and fatality<sup><a href="#core-r22" role="doc-biblioref" data-xml-rid="r22" id="core-body-ref-r22-5" href-manipulated="true" aria-label="Reference 22" data-to-manipulate="false">22</a></sup> were defined according to World Health Organization guidelines.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="core-t3fn6" role="paragraph" data-to-manipulate="true">The confidence interval could not be estimated because there were zero events among vaccinated participants.</div></div></div></figcaption><figcaption><div class="caption">Sensitivity Analysis.<a href="#core-t3fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t3"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t3" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t4"><figure class="table"><a class="open-in-viewer" href="#t4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2114114/asset/85333ff3-abda-4e23-8f58-c09aed435afa/assets/images/large/nejmoa2114114_t4.jpg" height="1732" width="2615" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Substudies<a href="#core-t4fn1" role="doc-noteref">*</a></th><th class="txxx-borders" colspan="5"><span>Effectiveness against Symptomatic Infection<a href="#core-t4fn2" role="doc-noteref">†</a></span></th><th class="txxr-borders" colspan="5"><span>Effectiveness against Asymptomatic Infection<a href="#core-t4fn3" role="doc-noteref">‡</a></span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#core-t4fn4" role="doc-noteref">§</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#core-t4fn4" role="doc-noteref">§</a></span></th><th class="xxxx-borders">Effectiveness % (95% CI)<a href="#core-t4fn5" role="doc-noteref">¶</a></th><th class="xxxx-borders" colspan="2"><span>Case Participants:<br>PCR-Positive<a href="#core-t4fn4" role="doc-noteref">§</a></span></th><th class="xxxx-borders" colspan="2"><span>Controls:<br>PCR-Negative<a href="#core-t4fn4" role="doc-noteref">§</a></span></th><th class="xxxr-borders">Effectiveness % (95% CI)<a href="#core-t4fn5" role="doc-noteref">¶</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxx-borders">&nbsp;</td><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><th class="xxxx-borders">Vaccinated</th><th class="xxxx-borders">Unvaccinated</th><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">0–13 Days after first dose</td><td class="xxxx-borders shading">1954</td><td class="xxxx-borders shading">38,814</td><td class="xxxx-borders shading">1864</td><td class="xxxx-borders shading">38,904</td><td class="xxxx-borders shading">−5.5<br>(−12.9 to 1.4)</td><td class="xxxx-borders shading">984</td><td class="xxxx-borders shading">26,988</td><td class="xxxx-borders shading">962</td><td class="xxxx-borders shading">27,010</td><td class="xxxr-borders shading">−2.6<br>(−12.8 to 6.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">≥14 Days after first dose and no second dose</td><td class="xxxx-borders">1074</td><td class="xxxx-borders">39,187</td><td class="xxxx-borders">1922</td><td class="xxxx-borders">38,339</td><td class="xxxx-borders">47.9<br>(43.6 to 51.9)</td><td class="xxxx-borders">516</td><td class="xxxx-borders">26,968</td><td class="xxxx-borders">645</td><td class="xxxx-borders">26,839</td><td class="xxxr-borders">22.2<br>(12.1 to 31.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Month after second dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">1</td><td class="xxxx-borders">867</td><td class="xxxx-borders">40,271</td><td class="xxxx-borders">3756</td><td class="xxxx-borders">37,382</td><td class="xxxx-borders">81.5<br>(79.9 to 83.0)</td><td class="xxxx-borders">781</td><td class="xxxx-borders">27,102</td><td class="xxxx-borders">2202</td><td class="xxxx-borders">25,681</td><td class="xxxr-borders">73.1<br>(70.3 to 75.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">2</td><td class="xxxx-borders shading">650</td><td class="xxxx-borders shading">39,402</td><td class="xxxx-borders shading">1948</td><td class="xxxx-borders shading">38,104</td><td class="xxxx-borders shading">72.5<br>(69.6 to 75.1)</td><td class="xxxx-borders shading">381</td><td class="xxxx-borders shading">27,038</td><td class="xxxx-borders shading">899</td><td class="xxxx-borders shading">26,520</td><td class="xxxr-borders shading">66.9<br>(61.9 to 71.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">3</td><td class="xxxx-borders">372</td><td class="xxxx-borders">39,030</td><td class="xxxx-borders">1040</td><td class="xxxx-borders">38,362</td><td class="xxxx-borders">70.6<br>(66.4 to 74.3)</td><td class="xxxx-borders">239</td><td class="xxxx-borders">26,982</td><td class="xxxx-borders">402</td><td class="xxxx-borders">26,819</td><td class="xxxr-borders">47.7<br>(37.3 to 56.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">4</td><td class="xxxx-borders shading">258</td><td class="xxxx-borders shading">38,829</td><td class="xxxx-borders shading">486</td><td class="xxxx-borders shading">38,601</td><td class="xxxx-borders shading">57.0<br>(48.6 to 64.0)</td><td class="xxxx-borders shading">120</td><td class="xxxx-borders shading">26,956</td><td class="xxxx-borders shading">132</td><td class="xxxx-borders shading">26,944</td><td class="xxxr-borders shading">11.5<br>(−17.1 to 33.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">5</td><td class="xxxx-borders">316</td><td class="xxxx-borders">38,776</td><td class="xxxx-borders">344</td><td class="xxxx-borders">38,748</td><td class="xxxx-borders">12.0<br>(−6.1 to 27.1)</td><td class="xxxx-borders">99</td><td class="xxxx-borders">26,956</td><td class="xxxx-borders">117</td><td class="xxxx-borders">26,938</td><td class="xxxr-borders">24.3<br>(−7.1 to 46.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">6</td><td class="xxxx-borders shading">230</td><td class="xxxx-borders shading">38,800</td><td class="xxxx-borders shading">251</td><td class="xxxx-borders shading">38,779</td><td class="xxxx-borders shading">12.8<br>(−9.1 to 30.3)</td><td class="xxxx-borders shading">125</td><td class="xxxx-borders shading">26,958</td><td class="xxxx-borders shading">124</td><td class="xxxx-borders shading">26,959</td><td class="xxxr-borders shading">−2.1<br>(−52.0 to 31.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">≥7</td><td class="xbxx-borders">75</td><td class="xbxx-borders">38,761</td><td class="xbxx-borders">97</td><td class="xbxx-borders">38,739</td><td class="xbxx-borders">27.8<br>(−1.4 to 48.7)</td><td class="xbxx-borders">29</td><td class="xbxx-borders">26,948</td><td class="xbxx-borders">25</td><td class="xbxx-borders">26,952</td><td class="xbxr-borders">−33.3<br>(−181.8 to 36.9)</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="#t4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"></a><div class="notes"><a class="open-in-viewer" href="#t4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t4fn1" role="paragraph" data-to-manipulate="true">In each analysis for a specific time-since-vaccination stratum, we included only participants vaccinated in this specific time-since-vaccination stratum and those unvaccinated. Only matched pairs of PCR-positive and PCR-negative persons, in which both members of the pair were either unvaccinated or fell within each time-since-vaccination stratum, have been included in the corresponding estimate of vaccine effectiveness. Thus, the number of case participants (and controls) varied across time-since-vaccination analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t4fn2" role="paragraph" data-to-manipulate="true">A symptomatic infection was defined as a PCR-positive test conducted because of clinical suspicion due to the presence of symptoms compatible with a respiratory tract infection.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t4fn3" role="paragraph" data-to-manipulate="true">An asymptomatic infection was defined as a PCR-positive test conducted with no reported presence of symptoms compatible with a respiratory tract infection — that is, the PCR testing was done as part of a survey or a random testing campaign.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="core-t4fn4" role="paragraph" data-to-manipulate="true">Case participants and controls were matched one to one according to sex, 10-year age group, nationality, reason for PCR testing, and calendar week of PCR test.</div></div></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="#t4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"><div class="label">¶</div></a><div id="core-t4fn5" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="#t4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg">Vaccine effectiveness was estimated with the use of the test-negative, case–control study design.<sup></sup></a><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11 r12" id="core-body-ref-r12-7" href-manipulated="true" data-to-manipulate="false">11,12</a></div></div></div></figcaption><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine against Symptomatic SARS-CoV-2 Infection and Asymptomatic SARS-CoV-2 Infection.</div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t4"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t4" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2114114_t4.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2114114</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r1-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r1-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r1-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] December 21, 2020, first using the BNT162b2 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and Drug Administration–approved protocol, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. <em>N Engl J Med</em> 2021;385:187-189.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r2-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_3_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMc2104974&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951357/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+BNT162b2+Covid-19+vaccine+against+the+B.1.1.7+and+B.1.351+variants.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=187-189&amp;doi=10.1056%2FNEJMc2104974&amp;pmid=33951357" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r2-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r2-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] messenger RNA (mRNA) vaccine </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] effectiveness of BNT162b2 against B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] variant during the study was B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r4-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] for the test-negative, case–control design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>h [...] for respiratory tract infections. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>i [...] after the first and second doses. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r3-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and 3 months later adding the mRNA-1273 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and Drug Administration–approved protocol, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Chemaitelly H, Yassine HM, Benslimane FM, et al. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. <em>Nat Med</em> 2021;27:1614-1621.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r4-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-021-01446-y" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34244681/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000671528900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=mRNA-1273+COVID-19+vaccine+effectiveness+against+the+B.1.1.7+and+B.1.351+variants+and+severe+COVID-19+disease+in+Qatar.&amp;publication_year=2021&amp;journal=Nat+Med&amp;pages=1614-1621&amp;doi=10.1038%2Fs41591-021-01446-y&amp;pmid=34244681" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r4-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r4-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] (Moderna) vaccine. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] variant during the study was B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r4-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] for the test-negative, case–control design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Qatar Ministry of Public Health. National Covid-19 vaccination program data, 2021 (<a href="https://covid19.moph.gov.qa/EN/Pages/Vaccination-Program-Data.aspx">https://covid19.moph.gov.qa/EN/Pages/Vaccination-Program-Data.aspx</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r5-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=National+Covid-19+vaccination+program+data&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r5-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] that at least 80% had received both doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r5-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of the population being tested every week. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r5-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] the mass scale of PCR testing in Qatar, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Coronavirus (COVID-19) vaccinations. <em>Our World in Data</em>, 2021 (<a href="https://ourworldindata.org/covid-vaccinations">https://ourworldindata.org/covid-vaccinations</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Coronavirus+%28COVID-19%29+vaccinations&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">World Health Organization. Tracking SARS-CoV-2 variants. 2021 (<a href="https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/">https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Tracking+SARS-CoV-2+variants&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r7-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] were dominated by the B.1.1.7 (or alpha) </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r7-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and B.1.351 (or beta) </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r7-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] transmission of the B.1.617.2 (or delta) </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Qatar viral genome sequencing data: data on randomly collected samples. <em>GISAID</em>, 2021 (<a href="https://www.gisaid.org/phylodynamics/global/nextstrain/">https://www.gisaid.org/phylodynamics/global/nextstrain/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Qatar+viral+genome+sequencing+data%3A+data+on+randomly+collected+samples.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] B.1.617.2 had become the dominant variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] of random positive clinical samples </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] the incidence of B.1.351 during this time, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] variant during the study was B.1.351, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Benslimane FM, Al Khatib HA, Al-Jamal O, et al. One year of SARS-CoV-2: genomic characterization of COVID-19 outbreak in Qatar. May 20, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.05.19.21257433v2">https://www.medrxiv.org/content/10.1101/2021.05.19.21257433v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=One+year+of+SARS-CoV-2%3A+genomic+characterization+of+COVID-19+outbreak+in+Qatar.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] B.1.617.2 had become the dominant variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] the incidence of B.1.351 during this time, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] variant during the study was B.1.351, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Hasan MR, Kalikiri MKR, Mirza F, et al. Real-time SARS-CoV-2 genotyping by high-throughput multiplex PCR reveals the epidemiology of the variants of concern in Qatar. <em>Int J Infect Dis</em> 2021 September 12 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.ijid.2021.09.006" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3425398/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000706527200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Real-time+SARS-CoV-2+genotyping+by+high-throughput+multiplex+PCR+reveals+the+epidemiology+of+the+variants+of+concern+in+Qatar.&amp;publication_year=2021&amp;journal=Int+J+Infect+Dis&amp;doi=10.1016%2Fj.ijid.2021.09.006&amp;pmid=3425398" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] B.1.617.2 had become the dominant variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] of random positive clinical samples </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] variant during most of these time periods. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] the incidence of B.1.351 during this time, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] variant during the study was B.1.351, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. <em>Vaccine</em> 2013;31:2165-2168.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r11-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2013.02.053" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23499601/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000318329400010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+test-negative+design+for+estimating+influenza+vaccine+effectiveness.&amp;publication_year=2013&amp;journal=Vaccine&amp;pages=2165-2168&amp;doi=10.1016%2Fj.vaccine.2013.02.053&amp;pmid=23499601" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r11-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] vaccine effectiveness against influenza </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] vaccinated and unvaccinated persons. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] result from variation in epidemic phase, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] rollout of vaccination during the study, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] by applying the following equation </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r11-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r11-8"><i aria-hidden="true" class="icon-return"></i><span>h [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t4" role="menuitem" data-target="#fv-body-ref-r11-9"><i aria-hidden="true" class="icon-return"></i><span>i [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>j [...] test-negative, case–control study design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>k [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Verani JR, Baqui AH, Broome CV, et al. Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls. <em>Vaccine</em> 2017;35:3295-3302.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2017.04.037" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28442231/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000403134200003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Case-control+vaccine+effectiveness+studies%3A+preparation%2C+design%2C+and+enrollment+of+cases+and+controls.&amp;publication_year=2017&amp;journal=Vaccine&amp;pages=3295-3302&amp;doi=10.1016%2Fj.vaccine.2017.04.037&amp;pmid=28442231" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] vaccine effectiveness against influenza </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] vaccinated and unvaccinated persons. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] by applying the following equation </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r12-5"><i aria-hidden="true" class="icon-return"></i><span>e [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r12-6"><i aria-hidden="true" class="icon-return"></i><span>f [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t4" role="menuitem" data-target="#fv-body-ref-r12-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] test-negative, case–control study design. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>h [...] test-negative, case–control study design, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>i [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. <em>N Engl J Med</em> 2021;385:585-594.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r13-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_14_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMoa2108891&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34289274/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000675554200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Covid-19+vaccines+against+the+B.1.617.2+%28Delta%29+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=585-594&amp;doi=10.1056%2FNEJMoa2108891&amp;pmid=34289274" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r13-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and the United Kingdom, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Sheikh A, McMenamin J, Taylor B, Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. <em>Lancet</em> 2021;397:2461-2462.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r14-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)01358-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34139198/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667322400021" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+Delta+VOC+in+Scotland%3A+demographics%2C+risk+of+hospital+admission%2C+and+vaccine+effectiveness.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=2461-2462&amp;doi=10.1016%2FS0140-6736%2821%2901358-1&amp;pmid=34139198" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r14-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and the United Kingdom, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Nasreen S, He S, Chung H, et al. Effectiveness of COVID-19 vaccines against variants of concern, Canada. July 3, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v1">https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r15-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+variants+of+concern%2C+Canada.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r15-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and SARS-CoV-2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] has been implemented, such as in Canada </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for respiratory tract infections. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Dean NE, Hogan JW, Schnitzer ME. Covid-19 vaccine effectiveness and the test-negative design. <em>N Engl J Med</em> 2021;385:1431-1433.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_17_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMe2113151&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34496195/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000693740100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Covid-19+vaccine+effectiveness+and+the+test-negative+design.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1431-1433&amp;doi=10.1056%2FNEJMe2113151&amp;pmid=34496195" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. <em>Sci Rep</em> 2021;11:6233-6233.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r17-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-021-85428-7" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33737535/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667581800033" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Characterizing+the+Qatar+advanced-phase+SARS-CoV-2+epidemic.&amp;publication_year=2021&amp;journal=Sci+Rep&amp;pages=6233-6233&amp;doi=10.1038%2Fs41598-021-85428-7&amp;pmid=33737535" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r17-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] characteristics of the population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] the young, working-age population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] proxy. With the young population of Qatar, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] population are 50 years of age or older, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">Al-Thani MH, Farag E, Bertollini R, et al. SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar. <em>Open Forum Infect Dis</em> 2021;8(8):ofab221-ofab221.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r18-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/ofid/ofab221" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34458388/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000728385400013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+infection+is+at+herd+immunity+in+the+majority+segment+of+the+population+of+Qatar.&amp;publication_year=2021&amp;journal=Open+Forum+Infect+Dis&amp;pages=ofab221-ofab221&amp;doi=10.1093%2Fofid%2Fofab221&amp;pmid=34458388" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r18-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r48" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] involved in mega-development projects. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Jeremijenko A, Chemaitelly H, Ayoub HH, et al. Herd immunity against severe acute respiratory syndrome coronavirus 2 infection in 10 communities, Qatar. <em>Emerg Infect Dis</em> 2021;27:1343-1352.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.3201/eid2705.204365" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33900174/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000650121700012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Herd+immunity+against+severe+acute+respiratory+syndrome+coronavirus+2+infection+in+10+communities%2C+Qatar.&amp;publication_year=2021&amp;journal=Emerg+Infect+Dis&amp;pages=1343-1352&amp;doi=10.3201%2Feid2705.204365&amp;pmid=33900174" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r48" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] involved in mega-development projects. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">Coyle PV, Chemaitelly H, Ben Hadj Kacem MA, et al. SARS-CoV-2 seroprevalence in the urban population of Qatar: an analysis of antibody testing on a sample of 112,941 individuals. <em>iScience</em> 2021;24:102646-102646.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r20-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.isci.2021.102646" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34056566/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000667301700075" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+seroprevalence+in+the+urban+population+of+Qatar%3A+an+analysis+of+antibody+testing+on+a+sample+of+112%2C941+individuals.&amp;publication_year=2021&amp;journal=iScience&amp;pages=102646-102646&amp;doi=10.1016%2Fj.isci.2021.102646&amp;pmid=34056566" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r20-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r20-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] exposure to SARS-CoV-2 infection in Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] or other confounders. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">COVID-19 clinical management: living guidance. Geneva: World Health Organization, January 25, 2021 (<a href="https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1">https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r21-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+clinical+management%3A+living+guidance&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r21-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r21-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] symptoms), as well as against any severe, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] critical, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] severity (acute-care hospitalizations), </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] (intensive care unit hospitalizations), </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] Covid-19 cases (acute-care hospitalizations </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r21-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] Covid-19 cases (ICU hospitalizations </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r21-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] Severity, </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r21-8"><i aria-hidden="true" class="icon-return"></i><span>h [...] criticality, </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r21-9"><i aria-hidden="true" class="icon-return"></i><span>i [...] Severity, </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r21-10"><i aria-hidden="true" class="icon-return"></i><span>j [...] criticality, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="core-r22" class="citations"><div class="citation"><div class="citation-content">International guidelines for certification and classification (coding) of COVID-19 as cause of death. Geneva: World Health Organization, April 20, 2020 (<a href="https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19-20200420-EN.pdf?ua=1">https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19-20200420-EN.pdf?ua=1</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r22-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=International+guidelines+for+certification+and+classification+%28coding%29+of+COVID-19+as+cause+of+death&amp;publication_year=2020" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r22-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] or fatal </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and fatality </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] Covid-19 cases (Covid-19–related deaths </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r22-4"><i aria-hidden="true" class="icon-return"></i><span>d [...] and fatality </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t3" role="menuitem" data-target="#fv-body-ref-r22-5"><i aria-hidden="true" class="icon-return"></i><span>e [...] and fatality </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="core-r23" class="citations"><div class="citation"><div class="citation-content">Vogels C, Fauver J, Grubaugh N. Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern V.3. February 9, 2021 (<a href="https://www.protocols.io/view/multiplexed-rt-qpcr-to-screen-for-sars-cov-2-b-1-1-br9vm966">https://www.protocols.io/view/multiplexed-rt-qpcr-to-screen-for-sars-cov-2-b-1-1-br9vm966</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r23"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Multiplexed+RT-qPCR+to+screen+for+SARS-COV-2+B.1.1.7%2C+B.1.351%2C+and+P.1+variants+of+concern+V.3.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="core-r24" class="citations"><div class="citation"><div class="citation-content">Jacoby P, Kelly H. Is it necessary to adjust for calendar time in a test negative design? Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8. <em>Vaccine</em> 2014;32:2942-2942.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r24-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2013.08.048" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24016812/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000336713000003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Is+it+necessary+to+adjust+for+calendar+time+in+a+test+negative+design%3F+Responding+to%3A+Jackson+ML%2C+Nelson+JC.+The+test+negative+design+for+estimating+influenza+vaccine+effectiveness.+Vaccine+2013%3B31%28April+%2817%29%29%3A2165-8.&amp;publication_year=2014&amp;journal=Vaccine&amp;pages=2942-2942&amp;doi=10.1016%2Fj.vaccine.2013.08.048&amp;pmid=24016812" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r24-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r24-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] result from variation in epidemic phase, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] rollout of vaccination during the study, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="core-r25" class="citations"><div class="citation"><div class="citation-content">Pearce N. Analysis of matched case-control studies. <em>BMJ</em> 2016;352:i969-i969.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.i969" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26916049/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000371116400004" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Analysis+of+matched+case-control+studies.&amp;publication_year=2016&amp;journal=BMJ&amp;pages=i969-i969&amp;doi=10.1136%2Fbmj.i969&amp;pmid=26916049" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="core-r26" class="citations"><div class="citation"><div class="citation-content">Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams &amp; Wilkins, 2008.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Modern+epidemiology.+3rd+ed.&amp;publication_year=2008" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">27.</div><div id="core-r27" class="citations"><div class="citation"><div class="citation-content">Stata statistical software: release 17. College Station, TX: StataCorp. 2021 (<a href="https://www.stata.com/">https://www.stata.com/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r27"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Stata+statistical+software%3A+release+17&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">28.</div><div id="core-r28" class="citations"><div class="citation"><div class="citation-content">Planning and Statistics Authority. Qatar monthly statistics. <em>State of Qatar</em> (<a href="https://www.psa.gov.qa/en/pages/default.aspx">https://www.psa.gov.qa/en/pages/default.aspx</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r28-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Qatar+monthly+statistics" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r28-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r28-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] characteristics of the population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] the young, working-age population of Qatar. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] proxy. With the young population of Qatar, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r28-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] population are 50 years of age or older, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">29.</div><div id="core-r29" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Yassine HM, et al. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. <em>J Travel Med</em> 2021 May 28 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r29-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jtm/taab083" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34050372/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000711240500008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Pfizer-BioNTech+mRNA+BNT162b2+Covid-19+vaccine+protection+against+variants+of+concern+after+one+versus+two+doses.&amp;publication_year=2021&amp;journal=J+Travel+Med&amp;doi=10.1093%2Fjtm%2Ftaab083&amp;pmid=34050372" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r29-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r29-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] effectiveness of BNT162b2 against B.1.351, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after the first and second doses. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">30.</div><div id="core-r30" class="citations"><div class="citation"><div class="citation-content">Tang P, Hasan MR, Chemaitelly H, et al. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar. August 11, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.11.21261885v1">https://www.medrxiv.org/content/10.1101/2021.08.11.21261885v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r30-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BNT162b2+and+mRNA-1273+COVID-19+vaccine+effectiveness+against+the+Delta+%28B.1.617.2%29+variant+in+Qatar.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r30-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r30-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] of B.1.617.2 during the summer of 2021 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r30-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 43 Qatar, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">31.</div><div id="core-r31" class="citations"><div class="citation"><div class="citation-content">Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. <em>Lancet Infect Dis</em> 2021;21(2):e26-e35.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r32"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S1473-3099(20)30773-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33125914/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000614630600003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=What+defines+an+efficacious+COVID-19+vaccine%3F+A+review+of+the+challenges+assessing+the+clinical+efficacy+of+vaccines+against+SARS-CoV-2.&amp;publication_year=2021&amp;journal=Lancet+Infect+Dis&amp;pages=e26-e35&amp;doi=10.1016%2FS1473-3099%2820%2930773-8&amp;pmid=33125914" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">32.</div><div id="core-r32" class="citations"><div class="citation"><div class="citation-content">Williams LR, Ferguson NM, Donnelly CA, Grassly NC. Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates. July 31, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.30.21260912v1">https://www.medrxiv.org/content/10.1101/2021.07.30.21260912v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r32"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Measuring+vaccine+efficacy+against+infection+and+disease+in+clinical+trials%3A+sources+and+magnitude+of+bias+in+COVID-19+vaccine+efficacy+estimates.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">33.</div><div id="core-r33" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Effect of vaccination and of prior infection on infectiousness of vaccine breakthrough infections and reinfections. July 30, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.28.21261086v1">https://www.medrxiv.org/content/10.1101/2021.07.28.21261086v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effect+of+vaccination+and+of+prior+infection+on+infectiousness+of+vaccine+breakthrough+infections+and+reinfections.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">34.</div><div id="core-r34" class="citations"><div class="citation"><div class="citation-content">Makhoul M, Ayoub HH, Chemaitelly H, et al. Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses. <em>Vaccines (Basel)</em> 2020;8:668-668.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r36-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/vaccines8040668" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33182403/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000601676700001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Epidemiological+impact+of+SARS-CoV-2+vaccination%3A+mathematical+modeling+analyses.&amp;publication_year=2020&amp;journal=Vaccines+%28Basel%29&amp;pages=668-668&amp;doi=10.3390%2Fvaccines8040668&amp;pmid=33182403" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">35.</div><div id="core-r35" class="citations"><div class="citation"><div class="citation-content">Usherwood T, LaJoie Z, Srivastava V. A model and predictions for COVID-19 considering population behavior and vaccination. <em>Sci Rep</em> 2021;11:12051-12051.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r35-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-021-91514-7" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34103618/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000663012100002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+model+and+predictions+for+COVID-19+considering+population+behavior+and+vaccination.&amp;publication_year=2021&amp;journal=Sci+Rep&amp;pages=12051-12051&amp;doi=10.1038%2Fs41598-021-91514-7&amp;pmid=34103618" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r35-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r36-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] have lower adherence to safety measures. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r37" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] be a progressive normalization of behavior. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">36.</div><div id="core-r36" class="citations"><div class="citation"><div class="citation-content">Andersson O, Campos-Mercade P, Meier AN, Wengström E. Anticipation of COVID-19 vaccines reduces social distancing. January 15, 2021 (<a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765329">https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765329</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r36-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Anticipation+of+COVID-19+vaccines+reduces+social+distancing.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r36-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r36-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] have lower adherence to safety measures. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r37" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] be a progressive normalization of behavior. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">37.</div><div id="core-r37" class="citations"><div class="citation"><div class="citation-content">Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? <em>BMJ</em> 2006;332:605-607.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r37"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.332.7541.605" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16528088/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000236314400023" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Risk+compensation%3A+the+Achilles%E2%80%99+heel+of+innovations+in+HIV+prevention%3F&amp;publication_year=2006&amp;journal=BMJ&amp;pages=605-607&amp;doi=10.1136%2Fbmj.332.7541.605&amp;pmid=16528088" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">38.</div><div id="core-r38" class="citations"><div class="citation"><div class="citation-content">Israel A, Merzon E, Schäffer AA, et al. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. August 5, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1">https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Elapsed+time+since+BNT162b2+vaccine+and+risk+of+SARS-CoV-2+infection+in+a+large+cohort.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">39.</div><div id="core-r39" class="citations"><div class="citation"><div class="citation-content">Thomas SJ, Moreira ED, Kitchin N, et al. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. July 28, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1">https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Six+month+safety+and+efficacy+of+the+BNT162b2+mRNA+COVID-19+vaccine.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">40.</div><div id="core-r40" class="citations"><div class="citation"><div class="citation-content">Mizrahi B, Lotan R, Kalkstein N, et al. Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine, preliminary study. July 31, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1">https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Correlation+of+SARS-CoV-2+breakthrough+infections+to+time-from-vaccine%2C+preliminary+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">41.</div><div id="core-r41" class="citations"><div class="citation"><div class="citation-content">Pouwels KB, Pritchard E, Matthews PC, et al. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. August 24, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1">https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r42-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+of+Delta+on+viral+burden+and+vaccine+effectiveness+against+new+SARS-CoV-2+infections+in+the+UK.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">42.</div><div id="core-r42" class="citations"><div class="citation"><div class="citation-content">Keehner J, Horton LE, Binkin NJ, et al. Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. <em>N Engl J Med</em> 2021;385:1330-1332.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r42-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_43_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2114114&amp;key=10.1056%2FNEJMc2112981&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34469645/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000691735900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Resurgence+of+SARS-CoV-2+infection+in+a+highly+vaccinated+health+system+workforce.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1330-1332&amp;doi=10.1056%2FNEJMc2112981&amp;pmid=34469645" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r42-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r42-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] waning of BNT162b2 effectiveness. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r46-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] time and according to calendar month. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">43.</div><div id="core-r43" class="citations"><div class="citation"><div class="citation-content">Israeli Ministry of Health. COVID-19 vaccine effectiveness against the Delta variant: Israel’s Ministry of Health report. 2021 (<a href="https://www.gov.il/BlobFolder/reports/vaccine-efficacy-safety-follow-up-committee/he/files_publications_corona_two-dose-vaccination-data.pdf">https://www.gov.il/BlobFolder/reports/vaccine-efficacy-safety-follow-up-committee/he/files_publications_corona_two-dose-vaccination-data.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r43-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+effectiveness+against+the+Delta+variant%3A+Israel%E2%80%99s+Ministry+of+Health+report&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r43-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r46-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] time and according to calendar month. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r43-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after the first dose, such as in Israel, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">44.</div><div id="core-r44" class="citations"><div class="citation"><div class="citation-content">Nanduri S, Pilishvili T, Derado G, et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines in preventing SARS-CoV-2 infection among nursing home residents before and during widespread circulation of the SARS-CoV-2 B.1.617.2 (Delta) variant — National Healthcare Safety Network, March 1–August 1, 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1163-1166.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r46-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7034e3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34437519/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000691315200006" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Pfizer-BioNTech+and+Moderna+vaccines+in+preventing+SARS-CoV-2+infection+among+nursing+home+residents+before+and+during+widespread+circulation+of+the+SARS-CoV-2+B.1.617.2+%28Delta%29+variant+%E2%80%94+National+Healthcare+Safety+Network%2C+March+1%E2%80%93August+1%2C+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1163-1166&amp;doi=10.15585%2Fmmwr.mm7034e3&amp;pmid=34437519" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">45.</div><div id="core-r45" class="citations"><div class="citation"><div class="citation-content">Rosenberg ES, Holtgrave DR, Dorabawila V, et al. New COVID-19 cases and hospitalizations among adults, by vaccination status — New York, May 3–July 25, 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1150-1155.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r46-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7034e1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34437517/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=New+COVID-19+cases+and+hospitalizations+among+adults%2C+by+vaccination+status+%E2%80%94+New+York%2C+May+3%E2%80%93July+25%2C+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1150-1155&amp;doi=10.15585%2Fmmwr.mm7034e1&amp;pmid=34437517" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">46.</div><div id="core-r46" class="citations"><div class="citation"><div class="citation-content">Puranik A, Lenehan PJ, Silvert E, et al. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. August 21, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v3">https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v3</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r46-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Comparison+of+two+highly-effective+mRNA+vaccines+for+COVID-19+during+periods+of+Alpha+and+Delta+variant+prevalence.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r46-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r46-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] time and according to calendar month. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r46-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and the United States, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">47.</div><div id="core-r47" class="citations"><div class="citation"><div class="citation-content">Flaxman A, Marchevsky NG, Jenkin D, et al. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). <em>Lancet</em> 2021;398:981-990.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r47"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)01699-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34480858/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000695130500024" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reactogenicity+and+immunogenicity+after+a+late+second+dose+or+a+third+dose+of+ChAdOx1+nCoV-19+in+the+UK%3A+a+substudy+of+two+randomised+controlled+trials+%28COV001+and+COV002%29.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=981-990&amp;doi=10.1016%2FS0140-6736%2821%2901699-8&amp;pmid=34480858" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">48.</div><div id="core-r48" class="citations"><div class="citation"><div class="citation-content">Planning and Statistics Authority. Labor force sample survey. <em>State of Qatar</em>, 2017 (<a href="https://www.psa.gov.qa/en/statistics/Statistical%20Releases/Social/LaborForce/2017/statistical_analysis_labor_force_2017_En.pdf">https://www.psa.gov.qa/en/statistics/Statistical%20Releases/Social/LaborForce/2017/statistical_analysis_labor_force_2017_En.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r48"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Labor+force+sample+survey.&amp;publication_year=2017" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">49.</div><div id="core-r49" class="citations"><div class="citation"><div class="citation-content">Bertollini R, Chemaitelly H, Yassine HM, Al-Thani MH, Al-Khal A, Abu-Raddad LJ. Associations of vaccination and of prior infection with positive PCR test results for SARS-CoV-2 in airline passengers arriving in Qatar. <em>JAMA</em> 2021;326:185-188.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r49"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2021.9970" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34106201/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000660117400002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Associations+of+vaccination+and+of+prior+infection+with+positive+PCR+test+results+for+SARS-CoV-2+in+airline+passengers+arriving+in+Qatar.&amp;publication_year=2021&amp;journal=JAMA&amp;pages=185-188&amp;doi=10.1001%2Fjama.2021.9970&amp;pmid=34106201" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">50.</div><div id="core-r50" class="citations"><div class="citation"><div class="citation-content">Hitchings MDT, Ranzani OT, Scaramuzzini Torres MS, et al. Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: a test-negative case-control study. April 7, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.04.07.21255081v1">https://www.medrxiv.org/content/10.1101/2021.04.07.21255081v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r52"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+CoronaVac+in+the+setting+of+high+SARS-CoV-2+P.1+variant+transmission+in+Brazil%3A+a+test-negative+case-control+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">51.</div><div id="core-r51" class="citations"><div class="citation"><div class="citation-content">Hunter PR, Brainard J. Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose: a reanalysis of a study of ‘real-world’ vaccination outcomes from Israel. February 3, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.02.01.21250957v1">https://www.medrxiv.org/content/10.1101/2021.02.01.21250957v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r52"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimating+the+effectiveness+of+the+Pfizer+COVID-19+BNT162b2+vaccine+after+a+single+dose%3A+a+reanalysis+of+a+study+of+%E2%80%98real-world%E2%80%99+vaccination+outcomes+from+Israel.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">52.</div><div id="core-r52" class="citations"><div class="citation"><div class="citation-content">Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. <em>Lancet</em> 2021;397:1725-1735.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r52"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00790-X" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33901423/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647813600027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+coverage+in+health-care+workers+in+England+and+effectiveness+of+BNT162b2+mRNA+vaccine+against+infection+%28SIREN%29%3A+a+prospective%2C+multicentre%2C+cohort+study.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=1725-1735&amp;doi=10.1016%2FS0140-6736%2821%2900790-X&amp;pmid=33901423" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">53.</div><div id="core-r53" class="citations"><div class="citation"><div class="citation-content">Daum RS, Siber GR, Ballanco GA, Sood SK. Serum anticapsular antibody response in the first week after immunization of adults and infants with the <i>Haemophilus influenzae</i> type b-<i>Neisseria meningitidis</i> outer membrane protein complex conjugate vaccine. <em>J Infect Dis</em> 1991;164:1154-1159.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r53-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/164.6.1154" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1955715/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1991GR66000016" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Serum+anticapsular+antibody+response+in+the+first+week+after+immunization+of+adults+and+infants+with+the+Haemophilus+influenzae+type+b-Neisseria+meningitidis+outer+membrane+protein+complex+conjugate+vaccine.&amp;publication_year=1991&amp;journal=J+Infect+Dis&amp;pages=1154-1159&amp;doi=10.1093%2Finfdis%2F164.6.1154&amp;pmid=1955715" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r53-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r53-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and other vaccines. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r53-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after vaccination or an immunologic effect. </span></a></li></ul></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> Riverhead, New York</span></div><div><span>Endocrinology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/784502/endocrinologist-peconic-bay-medical-center-riverhead-ny/?query=fjwp&amp;rid=3059">Endocrinologist - Peconic Bay Medical Center - Riverhead, NY</a></div></div><div class="nejm-widget_item"><div><span> New York City, New York</span></div><div><span>Ambulatory Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/887329/primary-care-internal-medicine-physician-ambulatory-care/?query=fjwp&amp;rid=16388">PRIMARY CARE INTERNAL MEDICINE PHYSICIAN - AMBULATORY CARE</a></div></div><div class="nejm-widget_item"><div><span> Durham, North Carolina</span></div><div><span>Chiefs / Directors / Dept. Heads</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/868654/duke-seeks-chief-of-physiatry/?query=fjwf&amp;rid=8149">Duke Seeks Chief of Physiatry</a></div></div><div class="nejm-widget_item"><div><span> Billings, Montana</span></div><div><span>Family Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/877580/family-medicine-physician-west-end/?query=fjwf&amp;rid=751">Family Medicine Physician West End</a></div></div><div class="nejm-widget_item"><div><span> Maine</span></div><div><span>Surgery, General</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/879137/generalist-with-breast-surgery-focus-desirable-coastal-town-in-new-england/?query=fjwf&amp;rid=5263">Generalist with Breast Surgery Focus | Desirable Coastal Town in New England</a></div></div><div class="nejm-widget_item"><div><span> Dayton, Ohio</span></div><div><span>Psychiatry</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/888383/psychiatrist-adult-outpatient/?query=fjwf&amp;rid=377088">Psychiatrist - Adult - Outpatient</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128720&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejmai%2Fregister%2Faifallpdf24%3Fpromo%3DOAFQF4NA%26query%3Dcm-rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Daifallpdf24&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2114114&amp;pubId=41290786&amp;placeholderId=101337&amp;productId=1007" target="_blank"><img src="/sda/128720/NEJ-AI-Fall24-300x250---002.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d6aed105070292-SJC">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d6aed105070292-SJC"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d6aed105070292-SJC"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$624900947$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$624900947$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$624900947$--></div></div><div class="mlt-body"><!--?lit$624900947$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$624900947$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$624900947$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$624900947$-->May 12, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2200797?query=recirc_Semantic" target="_self">Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar</a></div><div class="mlt-article-authors"><!--?lit$624900947$-->L.J. Abu-Raddad and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$624900947$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$624900947$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$624900947$-->Mar 31, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2118691?query=recirc_Semantic" target="_self">Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection</a></div><div class="mlt-article-authors"><!--?lit$624900947$-->V. Hall and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/correspondence" target="_self"><!--?lit$624900947$-->Correspondence</a> <span class="mlt-article-site-label"><!--?lit$624900947$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$624900947$-->Mar 17, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMc2119432?query=recirc_Semantic" target="_self">Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar</a></div><div class="mlt-article-authors"><!--?lit$624900947$--></div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$624900947$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$624900947$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$624900947$-->Nov 17, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2210058?query=recirc_Semantic" target="_self">Covid-19 Vaccine Protection among Children and Adolescents in Qatar</a></div><div class="mlt-article-authors"><!--?lit$624900947$-->H. Chemaitelly and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$624900947$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$624900947$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$624900947$-->Sep 02, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2107715?query=recirc_Semantic" target="_self">Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile</a></div><div class="mlt-article-authors"><!--?lit$624900947$-->A. Jara and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa2114114?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2114114" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2114114.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2114114"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2108544" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa — 5-Year Outcomes</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMoa2114583" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f1.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/21755fa7-b76f-4b1d-a183-00d2ea09ea80/assets/images/large/nejmoa2114114_f1.jpg" height="3438" width="2315" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Time Trend of Vaccinated Persons, SARS-CoV-2 Infections, and Vaccine Breakthrough Infections in Qatar.</div><div class="notes"><div role="doc-footnote">SARS-CoV-2 denotes severe acute respiratory syndrome coronavirus 2.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2114114_f2.jpg"><img src="/cms/10.1056/NEJMoa2114114/asset/d0c3ffb2-c5cc-4dc7-9cf2-68d68a8a241e/assets/images/large/nejmoa2114114_f2.jpg" height="3037" width="2640" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine.</div><div class="notes"><div role="doc-footnote">Data are presented as effectiveness point estimates, with 𝙸 bars indicating the corresponding 95% confidence intervals. Covid-19 denotes coronavirus disease 2019.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Demographic Characteristics of the Participants and Reasons for PCR Testing among Samples Used to Estimate BNT162b2 Vaccine Effectiveness.<a href="#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t2" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 2</div><div class="fv__item__description"><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine against Any SARS-CoV-2 Infection and against Any Severe, Critical, or Fatal Case of Covid-19.<a href="#fv-t2fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t3" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 3</div><div class="fv__item__description"><figcaption><div class="caption">Sensitivity Analysis.<a href="#fv-t3fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t4" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 4</div><div class="fv__item__description"><figcaption><div class="caption">Effectiveness of the BNT162b2 Vaccine against Symptomatic SARS-CoV-2 Infection and Asymptomatic SARS-CoV-2 Infection.</div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/385/24" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 385 No. 24</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Dec 09, 2021</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2110956" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">B. Pitt and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Dec 09, 2021</span></li><li data-toggle="tooltip" data-original-title="Visual Abstract" class="issue-item_meta-item"><span role="img" aria-label="Visual Abstract" tabindex="0" class="issue-item_visualAbstract"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-visual"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2109522" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">K. Ali and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Dec 09, 2021</span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2108544" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Brief Report: Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa — 5-Year Outcomes</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">M. Kueckelhaus and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2114114%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2114114&amp;pubId=41290786&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2114114%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2114114&amp;pubId=41290786&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright © 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id05138917340515463" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d6aed105070292-SJC" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d6aed105070292-SJC" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d6aed105070292-SJC"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d6aed105070292-SJC"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d6aed105070292-SJC"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d6aed105070292-SJC"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d6aed105070292-SJC">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d6aed105070292-SJC">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d6aed105070292-SJC"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d6aed105070292-SJC"></script>


    


            <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d6aed0f97c0292',t:'MTc0OTUzNTU4OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d6aed0f97c0292&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script><div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div>

        
        
    

<div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><iframe name="captureIFrame_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-transactionid="y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" id="captureIFrame_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" target="captureIFrame_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="✓" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="capture_screen"><input id="capture_signIn_js_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="js_version"><input id="capture_signIn_transactionId_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" type="hidden" class="capture_transactionId_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="capture_transactionId"><input id="capture_signIn_form_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="form"><input id="capture_signIn_flow_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="flow"><input id="capture_signIn_client_id_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="client_id"><input id="capture_signIn_redirect_uri_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="redirect_uri"><input id="capture_signIn_response_type_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="response_type"><input id="capture_signIn_flow_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="flow_version"><input id="capture_signIn_settings_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="settings_version"><input id="capture_signIn_locale_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="locale"><input id="capture_signIn_recaptcha_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_y1a3m7sjydclbteb1km3ynld8uksowfo9clhhcwd" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div><div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><ymy-umzrwrvtjxvk></ymy-umzrwrvtjxvk><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa2114114?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=3-10"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div></body></html>